干细胞之家 - 中国干细胞行业门户第一站

标题: 求助Development. 2011 Nov;138(21):4801-12.文献 [打印本页]

作者: chleiwu    时间: 2011-11-2 22:30     标题: 求助Development. 2011 Nov;138(21):4801-12.文献

Development. 2011 Nov;138(21):4801-12.
8 g1 u* _, Y: i/ E& O2 t( Y8 XER71 directs mesodermal fate decisions during embryogenesis.
/ \5 P5 y% f8 S3 |5 SRasmussen TL, Kweon J, Diekmann MA, Belema-Bedada F, Song Q, Bowlin K, Shi X, Ferdous A, Li T, Kyba M, Metzger JM, Koyano-Nakagawa N, Garry DJ.$ }+ `+ Q! i8 u0 h8 E- g
SourceLillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.
% E, O9 o  e) F, m3 _5 X9 K% k7 N% w2 L6 |! u
PMID: 21989919* ^: a4 a! ?/ ]0 ?1 l, Q3 a  p
http://www.ncbi.nlm.nih.gov/pubmed/21989919
作者: wang1234611    时间: 2011-11-4 09:39

1      ER71 directs mesodermal fate decisions during embryogenesis. 参考中文标题: 点击查看机器翻译 作      者: Rasmussen TL. Kweon J. Diekmann MA. Belema-Bedada F. Song Q. Bowlin K. Shi X. Ferdous A. Li T. Kyba M. Metzger JM. Koyano-Nakagawa N. Garry DJ. 全文及相关链接:HighWire Press     Swets Information Services     摘      要: Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for ER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse model by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the EYFP(+) population of cells in Er71 mutant and wild-type littermates. In the absence of ER71, we observed an increase in the number of EYFP-expressing cells, increased expression of the cardiac molecular program and decreased expression of the hemato-endothelial program, as compared with wild-type littermate controls. We also generated a novel Er71-Cre transgenic mouse model using the same 3.9 kb Er71 promoter. Genetic fate-mapping studies revealed that the ER71-expressing cells give rise to the hematopoietic and endothelial lineages in the wild-type background. In the absence of ER71, these cell populations contributed to alternative mesodermal lineages, including the cardiac lineage. To extend these analyses, we used an inducible embryonic stem/embryoid body system and observed that ER71 overexpression repressed cardiogenesis. Together, these studies identify ER71 as a critical regulator of mesodermal fate decisions that acts to specify the hematopoietic and endothelial lineages at the expense of cardiac lineages. This enhances our understanding of the mechanisms that govern mesodermal fate decisions early during embryogenesis. 参考中文摘要:Er71 nonviable突变和缺乏胚胎造血和内皮血统之中。进一步而言,需定义的功能作用在ER71细胞谱系的决定,我们产生转基因小鼠模型。我们策划的转基因小鼠模型Er71-EYFP通过熔断3.9 kb Er71赞助人EYFP记者的基因。使用FACS和转录的评价,我们仔细检查了EYFP(+)人口的细胞突变的、Er71野生littermates。在缺乏ER71,我们观察到一个数量的增长EYFP-expressing细胞,增加表达式的程序并减少心脏分子的表达hemato-endothelial程序,相比而言,野生littermate控制。我们也产生了一个新颖的Er71-Cre转基因小鼠模型使用相同的3.9 kb Er71推销员。研究表明,遗传fate-mapping ER71-expressing产生造血细胞和内皮血统的野生的背景。在缺乏ER71,这些细胞群体选择了mesodermal血统,包括心脏血统。延长这些分析中,我们使用了一个诱导胚胎干细胞/混合而且发现生命的性体系统ER71压抑的cardiogenesis品系。在一起,这些研究确定ER71作为一个至关重要的调节作用mesodermal命运决定说明造血和内皮血统的代价心脏血统之中。这加强我们对mesodermal决策机制控制命运的早期胚胎。出      处: Development (Cambridge, England). 2011年138卷21期4801-12页 相关链接: PubMed Google学术搜索 Google引文 外部引文 相关文献 引文追踪(Google)
作者: tmdabc    时间: 2011-11-6 13:17

回复 chleiwu 的帖子6 b5 c3 y0 C/ W

9 \0 i" ^. P( J: u5 X4801 RESEARCH ARTICLE. A) G: c4 i8 l' j3 t& ^. k
INTRODUCTION% ?* y6 H) K5 m  e$ m
Transcriptional networks, signaling cascades, microRNAs and2 \+ G) [% b5 y* v
other factors coordinately regulate stem and progenitor cell
6 Q5 R# K" t- z9 {5 t5 {populations to give rise to the mesodermal lineages (Davis and Zur
3 V- K$ }, H9 d" NNieden, 2008; Ivey et al., 2008; Omelyanchuk et al., 2009; Park et8 Y' S/ N. H3 y' z9 v
al., 1998). During embryogenesis, a set of anterior progenitors
8 X3 m1 A6 t7 n" N( ]7 |. V; ^coalesce to form the heart. These progenitors, along with the blood
1 v" ^/ E% V% q3 qand vasculature, comprise the circulatory system, which is the first$ J; ~$ g1 s8 i: i) b
organ system to develop in mouse and human. Disruption or
* r) u$ l, E) C4 r1 D: n& o. Nelimination of any one of these lineages results in early embryonic
1 `, J" |$ l$ X8 i/ A6 _9 B' I; s4 ]lethality. However, the factors that regulate the co-emergence of
& d( {" d( |& O6 d+ `1 n3 |0 i- Rthese lineages from the mesodermal progenitor pools are
4 I0 h: l, k( l" A8 B4 O) s  L4 |+ uincompletely defined.: i; e" X$ Y' K. a* c: c
Recent studies have identified a multipotent progenitor cell; O4 ^- N0 c0 o" a
population that is capable of giving rise to the cardiomyocyte and' x+ n* s  c8 X2 L6 s
endothelial lineages during embryogenesis (Kattman et al., 2006;
6 w9 r; ^. W. J7 w4 wMoretti et al., 2006; Wu et al., 2006). Although these multipotent
, {5 ?: I& _- r. g: Gprogenitors have been identified based on the expression of Flk1" o& X# E/ u" f/ H3 P; I2 V1 Z
(also known as Kdr), Nkx2-5 and Isl1, the transcriptional networks
" {8 J0 {/ c# t/ v6 f- Nthat govern the fate of these progenitors are unknown. These and: L( q4 i! g5 Z1 J# e2 f
other studies emphasized the plasticity and context dependence of
$ F) f: M# ?- C' x! wregulatory cascades in the progenitor cell populations. For example,/ V/ }3 P+ {8 h
our previous studies demonstrated that Nkx2-5 has a dual
! j+ g# m' Y- R. x: ^transcriptional regulatory role in the promotion of the cardiac
0 N/ p; L. d6 V" m7 elineage and suppression of the hematopoietic lineage (Caprioli et9 w- o  U% r% a. F! i* N! {$ d% k5 ?
al., 2011). In this fashion, we proposed that the stoichiometry of$ v+ F( S0 C) Z
regulatory transcription factors and interacting factors could7 u" m  s8 {; y9 l  m, L; _1 \
dynamically regulate the fate of progenitors. Definition of/ k, \, ]3 a: n! o
additional networks and signaling pathways that promote and  ?3 `: W4 f1 s/ G& b/ u) G
suppress the fate of distinct lineages that arise from multipotent1 m* |' I- u4 ]2 o6 v9 \
progenitors will enhance our mechanistic understanding of their  z& g& @. g+ I: _+ ~
developmental potential.. {$ n0 l2 e" J- A+ R9 n3 H
Ets-related protein 71 (ER71; Etv2) is a member of the Ets6 ]! Z3 F8 M& e2 e4 q: t% H
transcription factor family that we and others have shown to be
; z9 m( W' Y" W9 ?7 eessential for formation of the endothelial and hematopoietic
& C. s- k& i, X7 _lineages (De Val et al., 2008; Ferdous et al., 2009; Lee et al., 2008).0 d& g- n4 a0 V0 u  F4 d  d
Er71 can be induced by BMP, Wnt and Notch signals to promote
" Q9 H# b7 U( b3 Dhematopoiesis (Lee et al., 2008) and synergizes with FoxC2 to: j/ j7 B1 Y9 A5 ^- P7 Z
regulate the endothelial program by directly targeting Scl (also5 `2 c, V& V6 }- k
known as Tal1), Notch4, Cdh5 and Tie2 (also known as Tek) (De
2 s! f- L. _0 I: n0 I- {" d9 p+ vVal et al., 2008; Ferdous et al., 2009; Lee et al., 2008). In Er71. _9 ?7 A) i" z; l+ _5 u% e# X$ P6 r
mutant mouse embryos, there is a complete lack of hematopoietic
5 M/ x9 g! D. I* I6 o2 C% Y* ]: Sand endothelial lineages and the embryos are nonviable by6 ^* ?  U: ^  t' \3 E0 N
embryonic day (E) 9.5 (Ferdous et al., 2009; Lee et al., 2008).0 T- A9 n& q8 T) e1 H9 F; ^% I
Analysis of the Er71 mutant embryos revealed no differences in+ ?# v0 P: H0 A1 M# s
cellular proliferation or cellular apoptosis compared with age-& ?0 U0 F5 f( }* C2 T! {5 a" T' y
matched wild-type littermates (Ferdous et al., 2009). These results1 `8 q) c# F8 u+ {  Y: {% b8 H
raised the question of whether the hematopoietic and endothelial
& }" s& P8 s  Q! l+ I9 I" y" Bprecursors are still present but unable to differentiate to hemato-
6 i, g5 y6 L6 K; }' `- Wendothelial lineages, whether they had been redirected towards
8 l" t# f8 p1 G  q6 X3 T2 Cother lineages or whether these cells never arose during
( n: h4 u, Q) S. B9 O3 n8 M) I0 ?) Xdevelopment.7 O3 f) J/ u, B' K  F' J
Development 138, 4801-4812 (2011) doi:10.1242/dev.070912+ M) {) m8 L1 ]( N/ K
© 2011. Published by The Company of Biologists Ltd
- D1 j0 ~8 v6 Y1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.
7 o4 [9 b* \$ F5 y; J! q% H2Department of Integrative Biology & Physiology, Medical School, University of
0 V) B1 Y4 a* ^3 H! N6 M: fMinnesota, Minneapolis, MN 55455, USA.
; i0 C2 N: i/ T3 [3Biolead.org Research Group, LC" w$ K* }% E9 _8 @5 f" I
Sciences, Houston, TX 77054, USA. - z# [3 H5 c* V; f$ s: Z/ p3 `
4University of Texas Southwestern Medical5 R3 w& P7 U( B9 y; |
Center, Dallas, TX 75244, USA.4 Q& W; l' R) Y% G( Q- q* `# }
*Author for correspondence (garry@umn.edu)6 a  p8 A1 h3 ^$ n4 V
Accepted 5 September 20117 r7 V* O3 _- u2 }  V8 U5 u1 @/ j
SUMMARY$ [; l/ {. X) z5 n
Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for
3 G1 m# e' Y: N' P, @5 EER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse$ W! }" ~) |6 b8 n7 D6 f
model by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the
- h* L( ^! M  M4 kEYFP+ population of cells in Er71 mutant and wild-type littermates. In the absence of ER71, we observed an increase in the- V: v1 Q0 H& @3 K4 n* Z$ j2 Z, N7 p* d
number of EYFP-expressing cells, increased expression of the cardiac molecular program and decreased expression of the hemato-
# M7 Q; @; ~& q0 \) u* w- d$ E: zendothelial program, as compared with wild-type littermate controls. We also generated a novel Er71-Cre transgenic mouse8 Z/ k, S5 l: K: |% O  }
model using the same 3.9 kb Er71 promoter. Genetic fate-mapping studies revealed that the ER71-expressing cells give rise to the
0 ?' e5 X% d1 Z7 chematopoietic and endothelial lineages in the wild-type background. In the absence of ER71, these cell populations contributed
: c7 k- r! [) d" u5 P* s0 r7 X1 [, cto alternative mesodermal lineages, including the cardiac lineage. To extend these analyses, we used an inducible embryonic
( G2 W! }5 Q; T1 i2 [stem/embryoid body system and observed that ER71 overexpression repressed cardiogenesis. Together, these studies identify ER71. O& c( X& @: p6 S
as a critical regulator of mesodermal fate decisions that acts to specify the hematopoietic and endothelial lineages at the expense
3 i1 }( a& V; y. s  g3 U3 vof cardiac lineages. This enhances our understanding of the mechanisms that govern mesodermal fate decisions early during
' c! t* C! l" {: o; o) C( Z5 `6 Pembryogenesis.
  l8 I' g( q, t  _* g  U; mKEY WORDS: Transgenesis, Er71 (Etv2) knockout, Mouse+ i) n1 d0 n& k% v7 h/ Y# P. y6 A
ER71 directs mesodermal fate decisions during" P& ]8 W/ s7 [7 A/ \+ g. k' {1 ]
embryogenesis
3 E/ N6 f; c( C1 i# }Tara L. Rasmussen1, Junghun Kweon1, Mackenzie A. Diekmann1, Fikru Belema-Bedada1,2, Qingfeng Song3,
& k7 A: I0 @4 @( IKathy Bowlin1, Xiaozhong Shi' D& u* M& X- y8 ?7 t, A
1, Anwarul Ferdous4, Tongbin Li2 b1 S. q$ ~# m- O$ M. k
3, Michael Kyba1, Joseph M. Metzger1,2, 6 k- c& H- m1 j4 }4 K; v$ x
Naoko Koyano-Nakagawa1 and Daniel J. Garry1,$ v. g& H5 J+ \3 B% U
*
" f) _7 T. K+ @DEVELOPMENT48025 m7 {( C) d$ c
In the present study, we have dissected ER71-mediated
( ~2 C9 h3 H& v! P+ Zmechanisms that govern fate determination during murine
# G1 A: s# E% m; ?' L( {' X1 o/ ^, dembryogenesis. We have generated a novel transgenic mouse0 Z4 r/ y# i# P8 M
model in which the 3.9 kb Er71 promoter drives the EYFP reporter
4 |8 N' x" Y: }  ^& k- Q9 x" j9 y5 A(Er71-EYFP), and crossed it into the Er71 wild-type and mutant6 I$ @, x0 q. _+ m
backgrounds. This strategy facilitates the isolation and
" F0 r% U( A" g5 ~4 j' pcharacterization of cells that would normally express ER71 from
( ^, {$ Z6 L: P! ?2 p9 \- rEr71 mutant embryos. In the absence of ER71, we observed the8 m+ l' t" T( O" O' E5 o1 a; ?
conversion of cells that would normally give rise to lateral plate
! Y/ L" H! T, `4 |( L' b# vmesoderm into cells that produce paraxial and cardiac mesoderm.
* V4 B: Q! W8 b/ e9 `Furthermore, ER71 overexpression in vitro using an inducible
8 u# f: F7 V: l% B" h& f  {embryonic stem cell/embryoid body system demonstrated
* d' d' M2 l7 T' z$ U: G; @decreased cardiogenic potential. Collectively, these data* }* Z$ L' g) y# b3 O9 P4 b% r
complement and extend our understanding of the functional role of
+ }/ }# c* {- b" t( B, R6 OER71 to differentially promote mesodermal fate decisions during
# t3 s! Y! p; x* n6 Bembryogenesis.
5 I+ Z7 D7 \: g: c% v# XMATERIALS AND METHODS
/ |! d  x! R: r5 U9 m: qGeneration of transgenic mice% i- w; N# ~9 K/ c7 g" ?4 }
The 3.9 kb  Er71 promoter (Ferdous et al., 2009), which harbors the! ]1 T* s0 ?* R. e' r4 b7 {
modules necessary to direct the temporal and spatial expression of ER71,0 R5 r, E9 B' V6 g
was cloned into the pEYFP-1 vector (BD Biosciences) and into a
1 z3 X9 k; H; P2 O: O( d2 n0 |promoterless pBS-Cre-pA vector to generate the ER71-EYFP and ER71-
# z$ N5 D( e1 F; R0 o+ g: z. SCre constructs, respectively. Transgenic animals were generated at the! [" n* e6 g; k  M0 F- C. G
University of Minnesota Mouse Genetics Laboratory using standard
# r  }" L9 H1 @* ]- Z2 f+ m) Gmethods. Transgenic mice were screened for DNA integration by PCR.
8 n' ?* o* s# V: MExpression analysis of ER71-EYFP lines was performed by examining
# @7 B, A8 W* T) l+ uE7.0-9.5 embryos resulting from timed matings to wild-type CD1 mice
, t+ Y2 r- S5 x(Charles River). We also analyzed E11.0 and postnatal day (P) 3 offspring
0 m8 E% `" m# lof timed matings of the ER71-Cre lines and the Rosa-EYFP line (Jackson/ U' o. P* q/ n  O  U( d$ r
Labs 006148). Founder mouse lines were crossed to the  Er71- A, b) n9 o) V2 l+ x9 `) b
heterozygotes previously described (Ferdous et al., 2009). In all cases, at
" D2 m- F3 V/ ]5 u; }- xleast three transgenic lines were examined to confirm similar temporal and
4 L0 o. F  I. ?. V, t+ X; \* cspatial expression patterns. All mice were maintained at the University of: Y% z8 k. A0 c* N, Z$ G
Minnesota under protocols approved by the Institutional Animal Care and4 w' ~' L' s3 x  \& l9 O; }- A
Use Committee and Research Animal Resources.) G) t4 ]+ M! C% E# z, D
FACS analysis
7 r1 }4 f7 {! \- uEmbryos from timed pregnant females were harvested at specified stages.
% B  L8 e& z5 C! t$ O( vEmbryos were separated from yolk sacs, which were used for genotyping,
+ i4 c1 s2 J  j" Wand imaged on a Zeiss Axio Observer Z1 inverted microscope prior to0 f* e7 l6 q! d9 h% Z& m4 d
dissociation. Embryos between E7.5 and E9.5 were digested in 30-50 l, q) k; v/ M, h
0.25% trypsin plus EDTA at 37°C. Digestion was arrested with 500 l
# B8 q- g" ]! _0 G& E/ I1 Y( O. WDMEM containing 10% fetal bovine serum (FBS). Cells were pelleted at5 f$ f; Z- _! D$ R
4°C (1600  g), resuspended in PBS and passed through a 70  m cell8 h- W: j6 C5 s) U
strainer. Cells were incubated with antibody cocktails for 30 minutes,
5 s/ b& l0 d6 l/ Swashed, and resuspended in PBS. Cells were analyzed or sorted using a
8 p6 d5 W% O1 v5 f5 PFACSAria (BD Biosciences). Various combinations of antibodies (1:1000)0 l. M: E7 O, ]/ z# k+ R
were used, including Flk1-APC (eBiosciences 17-5821), Pdgfra-PE) M/ ~; x: }; S: H; {" b
(eBiosciences 12-1401), CD31-PECy7 (eBiosciences 25-0311), CD34-PE6 r1 f& M/ D$ m# X' w0 @+ p" f
(BD Pharmingen 551387), cKit-APC (eBiosciences 17-1171), CD41-
+ A; `8 R8 O% h8 m/ ]  nPECy7 (eBiosciences 25-0411), CD45-PE (BD Pharmingen 553081),
5 J+ h) d  H% MCD45-PECy7 (eBiosciences 25-0451-81), and Ter119-APC (BD
: j5 S" y# i0 q$ jPharmingen 561033) antibodies.; \0 {( l4 l# O4 v1 I$ L- h
Transcriptome analysis8 d9 @1 F7 O: Q( f' o* s( T$ X
Total RNA was isolated from 1000-5000 FACS sorted cells in TRIzol
% |9 ~( f. W/ r6 a(Invitrogen) using the PureLink Mini RNA system (Ambion). RNA was/ J: V6 f4 K1 Z6 M' \( r6 S! G$ o
subjected to two rounds of amplification using the MessageAmp II aRNA4 X; c8 t- z% k6 ^7 ~9 X
Amplification Kit (Ambion) and then labeled using the MessageAmp II-
/ g# S1 Q/ ?! u1 ^4 SBiotin Enhanced Kit (Ambion) according to manufacturer’s protocols.( f+ P3 A7 @+ N! N
Amplified RNAs were hybridized to Affymetrix mouse 430 2.0 full genome
3 ?' Y) w( Z% b3 L6 S* F. o6 C) warray chips at the BioMedical Genomics Center of the University of
; f, g5 K/ q& F4 v  fMinnesota. The CEL data files produced from Affymetrix array experiments$ C% H/ q9 U- f& ~( C
were processed using the affy package included in Bioconductor. The robust
2 @, A: u, Y  ^multi-array (RMA) method (Irizarry et al., 2003) was used to perform data
$ b! X7 q/ y$ ~normalization, background correction and expression quantification. The, o/ X1 ^  V0 l: Q- [0 |# h
limma package (Smyth, 2005) was used to identify differentially expressed0 O1 u9 r2 ^# z2 a' ?+ R" t
genes by ANOVA analysis, and false discovery rate (FDR) values were
1 q9 z0 H( Z; z! p# X2 D- jcalculated using the Benjamini-Hochberg method (Benjamini and Hochberg,
8 X' a% B8 g7 c4 K- u( M! Q* T1995). Average linkage hierarchical clustering analysis was performed using
; }, p% q- z3 M$ }6 fthe cluster program (de Hoon et al., 2004), with uncentered Pearson’s9 k/ T+ v% T0 ~# |( s4 k
correlation coefficient used to define pairwise similarity in gene expression.
. q# T4 K" r5 [, B2 LGenes annotated with the gene ontology (GO) term ‘heart development’
7 W" Z8 T) M/ K% d  B6 M. W$ ?(GO:0007507) were downloaded with AmiGO tool (Carbon et al., 2009) and1 B8 k& }# r8 Y$ i* l$ f) Y
used in producing the heatmaps. Microarray data is accessible in Gene; ?  _2 U0 f" @7 |. c! A* C
Expression Omnibus (series GSE32223).* d( J  y% @( c, Y2 _
Quantitative RT-PCR1 {+ e+ n& @7 h
Total RNA was isolated from 1000-5000 FACS sorted cells or embryoid
; R/ }3 M" T' p& z% x4 @body cells in TRIzol (Invitrogen) using the PureLink Mini RNA system.3 k9 m2 L% d  ~' T: m  C* I
RNA from FACS sorted cells was subjected to two rounds of amplification7 m9 A  ?" b8 E: `* q3 C4 }$ }
as described above, but left unlabeled. cDNA was made using random
$ x5 G# G6 j! s/ y& Rhexamers and transcript levels were determined using VIC-labeled (Gapdh,/ ?3 V$ g: {  F+ b
4352339E) or FAM-labeled (Er71, mm01176581_g1;  Scl,
; ], C/ j6 p0 o: P( umm01187033_m1; Cdh5, mm00486938_m1; Gata4, mm00484689_m1;% ^2 X5 M: f4 p5 o' R; _0 H
Tbx5, mm00803518_m1; Tnnt2, mm00441922_m1) TaqMan probe sets1 R. X2 m; c$ r; F$ U6 z
(Applied Biosystems).
% K9 s/ q  S0 [- f8 Y' G  I- n+ k7 QEmbryoid body differentiation and ER71 overexpression1 V1 `6 y, J7 V/ o. n, G5 u5 B
Doxycycline-dependent ER71-overexpressing mouse embryonic stem# L& A* g( [. F" w5 _2 u
(mES) cells were generated using an inducible cassette exchange strategy2 K+ I+ c% R# O
(Iacovino et al., 2009). In this system, ER71 tagged with a C-terminal HA
' `$ K" f- ~$ }  l4 \9 v8 oepitope was overexpressed in response to 0.5 g doxycycline. To mimic
" X% }% u9 l! F, }: p. e( k/ Bearly embryonic development, the mES cells were differentiated into, \+ Q/ V1 C# y; ~6 E* B& k# N2 N
embryoid bodies (EBs) using mesodermal differentiation media [1.5% FBS
* d1 }$ q3 V6 q; d+ E(Stem Cell Technology), 1 penicillin/streptomycin, 1 GlutaMAX8 Y+ g& {6 I. c
(Gibco), 100 g/ml Fe-saturated transferrin, 450 mM monothioglycerol, 50
& H8 y5 ~' ]8 i! T# t- ng/ml ascorbic acid in IMDM (Invitrogen)] (Kennedy et al., 1997). ER71" p; Q' {# I2 x9 B! }( m7 F: ^
was induced on day 3 after initiating differentiation and maintained through" T2 O, c6 N0 @5 w
day 10 by supplementing the differentiation media with doxycycline. On5 d: W2 ~, ~5 s# D' B; k1 s% m7 J
day 10, we fixed the EBs with 4% paraformaldehyde (PFA) and prepared
- l$ l7 z8 s# W/ {/ @cryosections. We stained adjacent sections with Hematoxylin and Eosin
; @8 i8 x( B9 Y" ^" ]5 t/ Wusing a standard protocol and performed immunostaining with mouse anti-
" @/ L( H9 p0 K( u. u+ w# N1 YTnT serum (1:200, DSHB clone CT3). We assayed the TnT-expressing area
2 A- ^$ O& U4 @' N9 E! |of each EB using ImageJ software (NIH) and calculated the ratio of the1 D' f' B2 L* s- l0 R5 ~+ @0 A
positive area to the total area from 33 sections of uninduced EBs and 42
  U1 h& n7 ~- \7 T7 ^! s" nsections of induced EBs. EBs were placed on laminin-coated coverslips
- `5 s/ ~1 q# c/ Land stimulated at 1 Hz. Edge detection (Ionoptix, Milton, MA, USA) was
/ p( k6 J5 @( Y7 U* N3 f8 e3 \used to measure contractility of intact EBs.
% y9 e: \% R- y8 B. [3 }2 |% XImmunohistochemical analysis
  M  k4 l, F, ]6 q8 B& c, L- V9 `Stage-specific embryos were harvested from time-mated pregnant females.
: q  |- Y* |. l" `9 V3 wFor paraffin sectioning, embryos were fixed for 4-8 hours at 4°C in 4%4 \5 D8 f: W, p+ Q6 `4 c+ |. S/ _
PFA and embedded. For cryosectioning, embryos were fixed for 1 hour at
; I$ @+ L5 A( P% |! R% v4°C in 4% PFA and embedded in OCT compound (Sakura). Sections were, c: n, ]# Y2 }9 Y
blocked with immunohistochemical diluent (2% normal donkey serum, 1%
3 a( A. _* @- |' l' u  C: ~bovine serum albumin, 0.3% Triton X-100, 0.02% sodium azide in PBS,
* o* g- ^1 q6 M' [, EpH 7.3) at room temperature and incubated overnight at 4°C with primary5 N0 {. O2 q! E& \
antibodies, including chicken anti-GFP (1:500, Abcam ab13970), rabbit
' b1 I& v/ ]1 c% d+ vanti-desmin (1:200, Novus Biologicals NB120-15200), rat anti-Tie2 (1:100,
! ]4 L6 C* u4 v& q* u: ?: PeBiosciences 13-5987-81), rat anti-Pdgfra (1:200, eBiosciences 12-1401-
" y( i( T4 j" A3 `6 s9 _81), goat anti-Nkx2-5 (1:500, Santa Cruz SC-8697) and anti-CD41 (1:100,9 q* c. \, @# Q1 A+ V9 [$ u
BD Pharmingen 550274), anti-Cdh5 (1:100, BD Pharmingen 55289), anti-. P* y% \9 _' r# F
CD31 (1:200, BD Pharmingen 550274), anti-Gata1 (1:100, Santa Cruz SC" U2 [- E5 W) D
265X) and anti-troponin T (1:200, DSHB CT3) sera. Slides were washed
$ X- N. R' @! ?and incubated with combinations of secondary antibodies (1:200) including
, u: b6 A0 k. d$ z: {) M. q/ santi-chicken Dylight 488, anti-rabbit Cy3, anti-mouse Cy3, anti-rat Cy3  p6 r" L8 x& {2 ~$ E2 f$ k2 b
and anti-goat Dylight 549 (Jackson ImmunoResearch Laboratories).+ j9 }: E) I4 f1 R8 t* I
Results were imaged on a Zeiss Axio Imager M1 upright microscope or a0 f8 S: Y. H$ L. ]8 |* B- A8 L
Zeiss LSM 510 Meta confocal microscope." \5 O! }) d2 P" y5 }
Statistical analysis' e. E2 p8 o. ~  C4 {: k/ C1 ^
Data represent the average of at least three replicates and s.e.m.
0 u" w, c* _; o6 U+ R3 ySignificance was tested by the Kruskal-Wallis test with the Dunn multiple
3 b. U2 G+ f$ r8 |0 y, ~" E# vcomparison test for more than two groups; for example, when comparing) X% `3 u5 o9 B4 k+ u
RESEARCH ARTICLE Development 138 (21)
# J2 S% E3 E! e' p* ^/ {0 YDEVELOPMENTwild type, heterozygous and homozygous mutants. Significance was tested- K% O- [, k: k* ?% w- h  l
by the Mann-Whitney U test for two groups. Analyses were performed& [4 e5 j1 e- p, G& l
using Prism5 software (GraphPad).
/ h  S  G% T- H0 {0 jRESULTS9 Y- C/ a, d' t1 M& r; f
Expression analysis of the ER71-EYFP reporter9 j; X% d, ~- |& h4 ]9 g7 v
Initial analysis of ER71 expression in the developing mouse& F# a' T) N' k: l
embryo was reported previously (Ferdous et al., 2009; Lee et al.,) c' X% D; @0 D& ]
2008). To further examine its potential role in cardiovascular
3 G7 f0 i. k' I* o5 d! d& z( Ndevelopment, we performed a detailed expression analysis of ER71
3 D  b3 @* y- M3 Pfrom E7.0 to E9.5, when Er71 mRNA is expressed (Ferdous et al.,1 g* r( \! O4 A4 P' x! j
2009). None of the commercially available ER71 antibodies' U. E0 L3 |" q& B3 g
detected the endogenous protein, so we utilized an Er71 transgenic* M0 U8 k/ W+ R3 G. n
mouse driving an enhanced yellow fluorescent protein (EYFP)
0 \; q: l! i  T2 p6 e7 Nreporter. The 3.9 kb region upstream of the Er71 transcription start2 r# Q* R: K$ k8 ]
site was fused to the  EYFP reporter (Fig. 1A). This promoter2 b8 H( T2 n- \$ [
fragment was previously shown to drive reporter expression that/ c& d# Q2 m2 O% q
recapitulated endogenous ER71 expression (Ferdous et al., 2009).4 t* X4 V- N; Z1 g
Four founder lines were generated with offspring embryos that: C: N" Q8 G, I
showed the same expression pattern.2 J: u9 ^. ^7 |; B* y
To examine the expression pattern of the EYFP reporter, we
( C, X9 e* v) ~, }+ }compared its expression to that of the angiopoietin 1 receptor Tie2,3 ?+ t: N% y/ Y+ I# `0 n# j( D
which marks endothelial cells in mice and humans (Dumont et al.,3 O* K- u3 D* y0 y! |# c
1992; Sarb et al., 2010; Schlaeger et al., 1997; Schnurch and Risau,
/ v3 g% m$ R& ~3 w! ]% M1993). The EYFP reporter (representing ER71 expression) was( w/ ]6 u) @$ ]' L5 s& c$ i5 U
expressed as early as the early to mid gastrulation stage (E7.0; Fig.
6 k! j# o* `: Q4 c2 y/ \4 F" Q8 G1B, bracket). At this stage, reporter expression was limited to the3 Z1 g0 q+ J7 W4 r( l8 F
extra-embryonic mesoderm (Fig. 1C) and showed co-expression
, z# }& @0 B- L4803 RESEARCH ARTICLE ER71 governs progenitor fates: v+ v8 v2 z0 W4 q& T/ h. {4 C: w7 s
Fig. 1. The transgenic ER71-' H- q7 y: M3 d! x
EYFP reporter is expressed
- |' K; Y$ s) |# kduring embryogenesis.
" |- Q, Q5 M9 t5 l(A)The transgenic Er71-EYFP2 N5 u( n* `, I3 U
construct used in these analysis.6 Z+ @. H" {3 v/ S! v# u
(B-Q)Expression analysis of mouse& f3 r' }' D( F
embryos between E7.0 and E9.5.
9 C$ ^, J, A; J* \4 sEYFP protein fluorescence (green)% i  b9 R. Y, k# S
is shown in whole-mount images
, c" J- t2 D& X6 M3 _(B,D,F,J,K,N). Sections were
+ ?) B  t' e. k$ [: Tstained with anti-GFP (green),% u( X' ~7 l1 X$ X; a2 T9 U& F
anti-Tie2 (red), anti-Nkx2-5 (red)
! w3 f) g( i3 x! }# E" kor anti-Pdgfra (red) antibody as
' p8 U; ~8 h0 K, @+ Y2 s" k  B5 Hindicated. DAPI nuclear staining is) M; p3 Z% R) Y: u& o6 u& K5 g
shown in blue. Yellow indicates8 }/ Q" V4 A! B
overlap of green and red
3 m. {# ~3 }0 G/ c+ w  Xchannels. (B-C) Early to mid
% \) `- }2 Y2 e6 a9 Vstreak stage, (D-E) early bud
1 e9 U2 @2 |  D, tstage, (F-I) early head-fold stage,
* ?* z- Z1 \' C) o+ G# i" \% Z(J-M) E8.5, (N-Q) E9.5; embryos7 Q# m0 c' b: |; r9 K5 I
were staged according to Downs
, ?7 v, P2 T, b0 K' Tand Davies (Downs and Davies,
$ M# F8 ]: U8 F# A: K. M9 k7 F7 P1993). Boxed regions are shown
! U: n# S+ x0 n5 Oat higher magnification; planes of1 K( [! G5 W$ i) T0 p1 W. G
sections are indicated. See first7 _! r0 g$ _+ {3 u& j' M
section of the Results for a
5 _- |# e+ Q6 ^/ C1 v! edescription of arrows, arrowheads3 f- {6 r- B* G; h/ H) u: r, n( u
and other labels. al, allantois; ba,
5 `7 V; e7 l' [) e) W# f' O. f/ vbranchial arch; bi, blood island;
5 |: Z( Z# v! g$ w! ^cc, cardiac crescent; cv, cardinal+ n* @5 o2 R, M8 O
vein; da, dorsal artery; ec,
& d7 q* ^' Y9 ^+ ?" Q( F/ Xendocardium; h, heart; hf, head, D* o3 w' k# T% I' l* @" m
fold; np, neural plate; nt, neural
& w) _+ ^$ V# y* x0 _- d' xtube; ph, pharynx; pm, paraxial9 N. Z3 C( Z  t* Q
mesoderm; s, somite; ys, yolk sac.
9 r4 f; l; K; m4 ?% NScale bars: 200m; 50m in5 E: ^6 E2 l0 E5 h" r
enlargements.: z6 g4 T' C7 V
DEVELOPMENT4804* L" g; _+ [! j7 G9 L
with Tie2 in the primitive blood islands (Fig. 1C,C, arrows) (Ema, ?; d4 Z- R" p( n0 w: i) J
et al., 2006b). EYFP was also weakly expressed in the mesothelial- p" l: W' I' T# U( u
layer of the yolk sac, but Tie2 was absent in this non-endothelial
) M/ h7 G  b' Kcell population (Fig. 1C,C, arrowheads). At E7.5, continued0 v7 L% v# k! c
expression of the EYFP reporter was observed in the extra-
4 O  v6 J- X6 M& Wembryonic mesoderm (Fig. 1D, bracket). In addition, scattered
; ]5 F/ G" d& ^( e, [EYFP+ cells were observed in the lateral plate mesoderm (Fig. 1D,
. z! b5 {6 H; b+ J' narrows). Transverse sections showed that these scattered cells co-" y( x, M7 V* j$ ^% _3 d
expressed Tie2 and most likely represent endothelial progenitors! H7 K' B, Z3 B" @7 G' g: B4 a# B3 W
(Fig. 1E,E,E), although Tie2 expression has also been identified
3 d& L8 Y4 S$ V$ rin a subset of cells committed to the hematopoietic lineage2 E8 u7 X- g0 m1 W
(Kisanuki et al., 2001; Li et al., 2005).
8 x6 v  I3 Q, X  s; J  zAt E7.75, the EYFP signal localized to discrete structures, }9 g  R! Q+ u' m7 h! r# x
including the cardiac crescent and the progenitors of the dorsal aortae
7 M7 K$ _  W; f(Fig. 1F, cc, arrows). We examined the expression in the cardiac
% v" r* n/ Q1 i# A2 x# ~* D, J" ]crescent and paraxial mesoderm in detail using Nkx2-5 and Pdgfra) ?3 s& G7 d* q+ d
antibodies (Fig. 1G-I). We observed that the EYFP signal overlapped
. k2 |1 a' e4 r9 zextensively with Tie2 within the cardiac crescent (Fig. 1G,G).& |2 I1 E/ m1 ]( T& Y
These EYFP+ cells are presumably endocardial progenitors (Misfeldt& ^5 g$ e% N: Q' O: h! d
et al., 2009). By contrast, EYFP+ cells either weakly expressed or did) R: O' G1 G/ ~- A) f
not express Nkx2-5 (Fig. 1H,H, arrows and arrowheads,
( i0 R  A- i* x+ u6 A: Rrespectively). We did not observe strong co-expression of Nkx2-53 i5 \4 m- u  {/ D# w
and EYFP. Pdgfra is strongly expressed in paraxial mesoderm and
& _) [/ e2 v& {1 c2 h. j6 bcardiac mesoderm (Fig. 1I, pm and asterisk). Double
. [+ g" O( m0 U" \% pimmunohistochemical labeling of EYFP and Pdgfra demonstrated
) E- h1 Q1 |( e0 L3 Dthat most cells either did not co-express these markers or weakly, a! {0 A) f: ]
expressed Pdgfra (Fig. 1I,I,I, arrowheads and arrows, respectively),7 B8 |% ]0 ]# S5 a$ N2 d/ Q. f
which is consistent with previous reports that the hemogenic lineage( ~( I/ N1 {3 }. t+ @* @8 |" [
is segregated from the paraxial mesoderm early during gastrulation
' g0 ~6 `' ^9 B! l(Kataoka et al., 1997; Takakura et al., 1997).
0 i$ @1 q' [0 O& F% @$ vAt E8.5 and E9.5, we observed localization of the EYFP signal to
6 T" ^8 F4 i% \) Rvascular structures throughout the embryo proper (Fig. 1J,N; arrows9 \+ F. d7 M5 x& k$ L4 o
point to the dorsal aorta and arrowheads indicate intersomitic vessels)# f- N& j' ?1 W6 A. G1 d2 v
and yolk sac (Fig. 1K). Transverse sections of the embryos (Fig.
1 A" @1 T3 `- K1L,M,O,P) showed localized expression in the vessel structures
) s# M' x2 k) F6 G8 zincluding dorsal aorta, cardinal vein, intersomitic vessels* r' D, S- r& B* \0 J
(arrowheads in Fig. 1M) and the endocardium (arrowheads in Fig.
0 W3 a7 M8 z$ G- h: c/ N3 ]1L). The expression of EYFP largely overlapped with that of Tie2,, |/ q1 @7 m( a3 Y2 |" D* i+ c3 b
indicating that the  Er71 promoter is active in early embryonic1 M( K1 a" T7 V6 y5 b$ g
endothelial and hematopoietic cells (Fig. 1O-P). We also observed
5 G/ b& ?9 y/ `! b1 |that EYFP was co-expressed with the hematopoietic transcription" {1 F, \+ w2 Z& X- S
factor Gata1, the cell surface marker of hematopoietic progenitors$ d3 F' q- d5 W6 Z2 ~, e- a
CD41 (also known as Itga2b), the marker of hematopoietic and6 y7 \7 m( T- J# ~5 s5 Z: P  [
endothelial lineages Cdh5, and with the primarily endothelium-' v2 p- p# V* \& l' h$ S. }
specific cell surface marker CD31 (also known as Pecam1)6 b& O& F* j; f7 i: Y, J5 U
(supplementary material Fig. S1). By E9.5, Nkx2-5 was localized to
$ R. r2 p" {( j% L& s4 n: j9 x9 zthe myocardial layer of the heart and did not overlap with EYFP
  `/ u' e- V4 i3 G/ Qexpression (Fig. 1Q, arrowheads; compare with 1O).
/ a' d3 @; \. RReporter expression is mislocalized in the Er71  Y' Z- j' M( T  s# E* c6 A
mutant
3 C; |7 A; z% rIn the Er71 mutant, the hematopoietic and endothelial lineages are
9 M0 T: t1 V. u) W+ s% S$ Zabsent. However, no changes were observed in cellular
) U) D& \. `+ q5 i6 [4 Uproliferation or apoptosis in the Er71 mutant embryo (Ferdous et
) L2 ~& [2 ?# \3 `* ?: v1 Z) Y" _al., 2009). Therefore, we crossed the ER71-EYFP reporter line into* ~' U1 U: W: p' @
the Er71 mutant background to define and characterize the cells+ H0 w7 T3 }. x+ w1 A* @
that should give rise to these lineages (Fig. 2). In the E7.75 wild-
# }; E) V# ~2 d& L! E/ J) o! utype embryo, EYFP expression was observed throughout the
- c- ]4 V' k9 I# m! U( Ycardiac crescent, the dorsal aortae and the extra-embryonic
5 F9 C- b4 V- Gmesoderm (Fig. 2A). By contrast, in the E7.75 mutant embryo the) j$ G' D" F( \( I: k
expression pattern was less definitive. EYFP-positive cells were6 E- U& n: z2 `7 Y& L
found in the extra-embryonic tissue; however, expression of EYFP
1 i% Y. R7 L3 s1 a+ _# Ewithin the embryo proper was mislocalized (Fig. 2B, arrow). EYFP9 m8 o& s) h! @+ F7 n% Z
expression appeared diffuse throughout the cardiac crescent (Fig.$ h* j7 A" S% v+ D: _7 t- ]# D1 n
2B, asterisk). In the wild-type embryo at E8.0, EYFP expression" [. ^# L/ F) A& ~% [
was observed specifically in the dorsal aortae, but not on the
6 h& b4 J6 k3 |) Z& Kperiphery of the embryo (Fig. 2C, arrowheads). EYFP expression: h. [  K: \$ j: P
was also observed in the presumptive endocardium within the+ k# a3 u3 K" L( H. m& \  n) [
linear heart tube (Fig. 2C). By contrast, the Er71 mutant embryos
+ K- T7 n5 j- k( F$ U) ?expressed EYFP only at the periphery of the embryo, which is# k0 p3 r( x" j- A- C7 y( E; N
likely to represent paraxial mesoderm (Fig. 2D).
9 S" c  g$ q- ~0 I( _9 c# lImmunohistochemical analysis of ER71-EYFP and Pdgfra, a
' R# G3 I3 c1 `( V, [5 _marker of paraxial mesoderm, expression in E8.5 wild-type and7 Y- B- R) U& ~
mutant embryos demonstrates that EYFP-positive cells are. ]- K/ y( x5 j! X
interspersed within the Pdgfra-positive mesoderm (supplementary
! j- A' q, \# C$ g5 ^; vmaterial Fig. S2). FACS profiling showed that the frequency of  H( Q0 d2 @' B/ n2 g& y
EYFP+ cells was increased in the Er71 mutant compared with the
$ t: f1 z6 {6 S, Zwild-type control at E8.0 (Fig. 2G-I), but not at E7.75 (Fig. 2E,F,I).5 K* l+ ]' m9 n1 f
The apparent increase in the percentage of EYFP+ cells could be
8 v1 _- Z- L2 r; b3 [due to a reduction in the total number of cells without a change in+ s% b# `" k% u
the number of EYFP+ cells, as cell viability can be reduced by a0 g1 w7 i5 C9 r- L) _" z
lack of vascularization. However, we ruled out this possibility as, ]: q- n( H  k( w. o# r
we also observed a doubling in the absolute number of EYFP+ cells
% r" t7 I  B/ rin E8.0  Er71 mutant embryos as compared with wild-type/ R* }. g" ?8 y1 t4 y' c" Z$ q, \
littermates (Fig. 2J).0 a8 i! j; {" T* s5 i
These analyses demonstrated that cells that expressed the ER71% D% W. M. z2 C' J, x; S' r
reporter were not only present in the Er71 mutant embryo, but were
+ Q$ q, c4 p' `5 s; a1 v3 ]also expanded in number. Since the Er71 mutant embryo lacks1 p6 ~' u* n' k
differentiated endothelial and hematopoietic lineages, we examined
1 X" s# s, r2 P( i1 [8 W1 ^whether these EYFP+ cells were arrested progenitors or cells% a- a7 f, k4 Y* C
redirected to other lineages. We used FACS analysis to examine the! T# c1 N/ P0 u1 N* c
cell surface markers of the EYFP+ cells in the Er71 mutant and: n* G* p3 B5 A+ f
wild-type backgrounds. Previous studies have established that
+ q! j/ z% {/ \2 l! }7 t+ oPdgfra is expressed in the primitive streak at E7.0, but is restricted
# a: f$ n4 O+ w  H4 t! M* D8 Tto the paraxial mesoderm at the early head-fold stages (Takakura
, \7 e9 w: S% v% aet al., 1997). Flk1 is expressed more broadly in mesodermal
6 P: n' j6 R/ V: dprecursors (Ema et al., 2006a; Motoike et al., 2003), including the3 g/ P* K. C( `( j  m3 h7 t  C
posterior portion of the primitive streak. Flk1+/Pdgfra–- K# h) w  W* y0 h1 g+ t# t
cells mark
8 |: r" [! x  `- N: l" H7 Xlateral plate mesoderm that will give rise to the endothelial and
7 h1 q, [3 u6 G) qhematopoietic lineages and Flk1–. J4 I  ~8 c3 W
/Pdgfra+ cells mark the paraxial# Y7 m  E% ^! ~; U: W! Z: |
mesoderm. Flk1 and Pdgfra are known to be co-expressed in the
- s2 p9 v0 n7 q* ~cardiac crescent (Kataoka et al., 1997) and in cardiac progenitors
6 S% b9 p$ G+ A- i4 i) P. {of embryoid bodies (EBs) (Bondue et al., 2011; Kattman et al.,6 _3 D; h" q0 b
2006). In the present study, the frequency of Flk1+ cells within the" b# B9 Q& }; L7 h: _3 K
EYFP+ population was significantly reduced at E7.75 and E8.04 L+ J! k* f; B. J/ @6 w2 r* H
(Fig. 3A,B,D,F). CD41 (Fig. 3D,E) and CD34 (Fig. 3E,F)
) S; T1 X! W3 c( _1 J' A* _expression was essentially absent at E8.0 in the EYFP+ cells of the; ^5 |0 A$ i3 ]0 B/ N4 y
Er71 mutant. These results show that the lateral plate mesoderm
1 x' E& V9 _) G4 A% L% {lineage and its derivatives, i.e. the hematopoietic and endothelial, k' f% G9 ]& G
lineages, are reduced in the Er71 mutant.) [! p: a0 f+ Z9 S7 |
In order to assess which lineages are expressing ER71-EYFP, we( m9 V7 T% A/ v+ g+ E7 Y2 {! H
analyzed the EYFP+ cells using Flk1 and Pdgfra antibodies.) W- o! {. G9 H: B% `5 A8 Z
Concurrent with the decrease of Flk1 expression at E7.75 and E8.0,3 R' Q2 O! ]& y' v
we observed an increase in the frequency of EYFP+ cells that
! C- l% W( Z5 j( V5 Z/ q9 gexpress Pdgfra (Fig. 3A,B). This correlated with a significant
+ [" i& k$ [" j) @$ X' f0 Pincrease of Pdgfra single-positive cells at E7.75 and a significant/ u7 ~) T. c9 @: B6 a( Y# D
increase of Flk1+/Pdgfra+ cells at E8.0 (Fig. 3A,C). There was also
5 W; d: C( a) K5 o0 i( ja trend toward expansion of Pdgfra single-positive cells within the
1 Q8 f( E; v5 K: M7 @( xEYFP+ population at E8.0 (Fig. 3A,C). To support these2 y1 m; k# w1 v( }
observations, we used immunohistochemistry to analyze the EYFP
: d# ^/ [! ]/ i* ~# {8 Bexpression patterns. In wild-type embryos, EYFP expression is) Q4 D/ R) c3 @) y
distinct from Pdgfra+ paraxial mesoderm. A select number of2 F6 _& M$ k. T2 l8 o1 @3 g
EYFP-positive cells are found within this region; however, these
( h8 @9 \& V5 Jcells are Pdgfra–
$ }8 n7 A2 H- M( d* A(supplementary material Fig. S2A,B). In mutant
5 d* l( e. m7 z' z1 NRESEARCH ARTICLE Development 138 (21)
5 u) S+ }  ]6 T8 kDEVELOPMENTembryos, many EYFP+ cells are found within the Pdgfra+ paraxial
5 \: b3 u5 L' ~& P+ R& \mesoderm. Some of these cells are double positive for EYFP and( v4 O3 ]  D/ Z/ v& f" m4 y
Pdgfra (supplementary material Fig. S2C,D). Likewise, in wild-
( U6 |: [! [# H: `type embryos, EYFP expression is distinct from troponin T (TnT)9 h5 [4 {) m; a$ ]& b5 f: y
+
. M8 f4 Z3 M/ M1 @9 [' ycardiomyocytes (supplementary material Fig. S2E). However, in
2 e8 t5 {. h. S: M" y" ]9 n5 |mutant embryos double-positive cells are found (supplementary, s3 h! B( n- [
material Fig. S2F,G, arrows). One interpretation of these data is& p0 \; s4 i: w0 v; W" x
that, in the absence of ER71, the EYFP+ progenitor cells
# w$ B5 |: T; U4 Y8 x9 Y' Sdifferentiate towards the paraxial (Flk1–
6 Z. w4 s- ^% b7 L& D6 u) z. g/Pdgfra+) and cardiac% H' p% S6 A) Q$ A  N
mesodermal (Flk1+/Pdgfra+) lineages at the expense of the lateral* W+ W" Y* N* Q1 R+ \! @! A2 |
plate/hemangiogenic mesodermal (Flk1+/Pdgfra–
9 a* V$ [$ @# M; Q; r) lineage.
0 g. W8 l- G; kAn alternative explanation of these results is that EYFP is  B3 A! I% U/ X" o) `7 p5 u$ s: n
expressed ectopically in cardiac (Flk1+/Pdgfra+) and paraxial4 ~/ `' z/ |5 D/ E
(Flk1–; A: p' K0 ]* u( A2 G
/Pdgfra+) mesodermal populations in the absence of ER71.
6 q; w$ z7 q# S* M* ?/ hIf this were the case, we would expect the cardiac and paraxial$ l! e: Y& T* \' I0 k
mesodermal populations within the EYFP–
. a' i+ g) N: a. tgate to decrease in5 x+ `( U- g9 O) s7 m
the mutant embryos because these cells expressed EYFP and8 t6 u& B* b* r# G2 w
would be included in the EYFP+ gate. Furthermore, we would) X2 _. n5 M  P  i' c2 E
expect no change in the overall representation of these markers
9 ~+ L4 G  o, Q. d# L' T$ ^in the unfractionated (the sum of EYFP+ and EYFP–
: U; a# e. i$ I( g3 y0 N& B$ g) gate. To2 e8 P4 u+ ]% z! |7 l
examine this possibility, we analyzed unfractionated cells from2 }1 z  h* Z- k: h
the whole embryo as well as EYFP–
6 K# V: X1 ]( m- @" tfractionated cells. In the
* b3 v: K2 b7 ~: YEYFP–
1 z: ?0 L+ C5 Q+ l: M8 ffraction no changes were observed in the mesodermal& N1 o& ^6 f8 T, _( ^
populations at E7.75 (supplementary material Fig. S3C,D) and( Y1 p! c) u% G# h6 X
E8.0 (supplementary material Fig. S3G,H). Analysis of the' u/ ~2 t6 E: z# B9 j$ |, M' f
whole population (the sum of EYFP–+ ~) u4 p+ u* }/ D
and EYFP+ gates) showed
5 [# j2 k: R3 Nno change in cardiac or paraxial populations at E7.751 U  W% C" E; h9 i8 D( I' e
(supplementary material Fig. S3A,B); but at E8.0, we observed
  K! K. g, N; \$ `9 q0 D1 w7 [a small, but reproducible, increase in the cardiac mesoderm
0 ]' x* L8 J3 \7 n/ Q5 v8 {  ~(Flk1+/Pdgfra+) (supplementary material Fig. S3E,F). We predict$ s& w$ P( j+ R( z4 a5 X
that the increase in cardiac mesoderm in the whole embryo is/ y8 r# j( C- f2 T* c$ j/ e
small because the EYFP+ population is a minor fraction of the
1 R- y' s3 I2 _0 Xentire embryo.
2 C/ W$ T+ H" {" O% o2 _3 OCollectively, our results support the model that, in the Er71: c) i" q4 Y% X' v
mutant background, EYFP+ cells differentiate to the cardiac
) l. f+ C  y: W7 U6 Rmesoderm lineage and contribute to the increase in cardiac2 ?# Q3 k+ q! b1 L4 T$ _
mesoderm (Flk1+/Pdgfra+) markers, rather than cardiomyocytes or5 ]- P* w. O  f* u( A3 Y: [
cardiac progenitors ectopically expressing EYFP.
0 X; S# `5 E& c+ M7 }4805 RESEARCH ARTICLE ER71 governs progenitor fates! A# K" S: x$ c$ Z3 T; J% J
Fig. 2. The ER71 reporter is misexpressed in Er71 mutant embryos. (A-H)EYFP expression in Er71 wild type (A,C,E,G) and mutant (B,D,F,H)
* W1 V* s3 K% t+ u8 ^4 xmouse embryos at E7.75 (A,B,E,F) and E8.0 (C,D,G,H). Asterisks indicate the cardiac crescent (A,B) or forming linear heart tube (C,D). Arrowheads& A$ V  X% e8 r" ~/ y' Y- ^
indicate the bilateral dorsal aortae (C,D) or its progenitors (A,B). Arrows point to regions in which EYFP is misexpressed in the mutant (A-D).6 p$ q/ O# \$ p  G# _
Representative FACS profiles of individual embryos (E-H) show the percentage of EYFP positive cells per embryo. Scale bars: 200m. (I)The2 }7 c+ N6 n% R9 b
percentage of EYFP+ cells for all experiments. (J)The average number of EYFP+ cells sorted per embryo. WT, wild type; HET, Er71 heterozygote; MT,; Y) M; m( P3 [, r. v2 F' `* T# `& m
homozygous Er71 mutant. ***, P<0.001. Error bars indicate s.e.m.
. \, d" E2 T! P/ |& DDEVELOPMENT48068 z( a( g: \9 p' p, r, ]) u4 Q1 K
Cardiac and skeletal muscle genes are
$ \7 T: R* S0 ?( ~% L" h  Kupregulated in ER71-EYFP+ cells in Er71 mutant
3 ]& f1 O8 T$ F6 w: yembryos8 a" S) M+ G) l5 Q' O: {% _
To further examine whether the EYFP+ cells in the absence of* w4 K& v) o$ Y& [9 h8 ~2 J
ER71 were redirected to other mesodermal lineages, we performed% q4 n6 w% B5 P; w1 W5 w# w# r
a transcriptome analysis. We used an Affymetrix microarray
6 F+ Z! }& n  ~2 T1 F7 [1 L! ]platform and examined the EYFP-positive and EYFP-negative
+ ^& {  V. K$ Q0 Q3 Z) Xcells from wild-type and Er71 mutant littermate embryos. Genes7 n% X7 v! F+ o
that were significantly dysregulated were filtered based on the false
* E- u! B8 P$ S- H$ ?, N6 f4 hdiscovery rate (FDR<0.01 for EYFP+ versus EYFP–1 D. k" v0 a: u, C$ X* i3 I  v2 H
; FDR<0.35 for9 U  k3 u; ]! i& r
wild type versus mutant; FDR<0.01 for the interaction between
) S' Y7 ^& G/ Q3 o6 l% k6 f' m8 Qthese two variables). Clustering analysis was carried out! z4 H2 F* R7 q5 ^
subsequently (Fig. 4A). Interestingly, there were no transcripts that$ z% `7 O: K; J6 i" f
showed differential expression between EYFP–3 J! V5 `4 {4 S. ?
populations in the1 }0 v6 E; U, P$ `3 V
Er71 wild-type and mutant backgrounds. Also, the cluster analysis( {  x$ v5 n. @
was unable to resolve differences between the EYFP–( `9 z/ X$ ]: s7 {% H: f/ O$ f
populations( y  a; f, l. D1 n, X) l* w. x
RESEARCH ARTICLE Development 138 (21)3 R' z* u4 I; X, [& w, j
Fig. 3. ER71-EYFP+ cells in Er71 mutant mouse embryos lack markers of hematopoietic progenitors in exchange for those of other3 J7 c. f8 t( S0 P0 ?! D  _' c
mesodermal lineages. (A)Using fluorophore-conjugated antibodies and FACS analysis, we observed an enrichment of Pdgfra+ cells in ER71-EYFP+5 @3 \3 M! Y% v
mutant cells at E7.75 and E8.0. (B,C)Summary of multiple experiments comparing individual fluorophores Flk1 and Pdgfra (B), and combinations of, h$ c) c0 X; t
Flk1 and Pdgfra (C). (D,F)Hematopoietic progenitor cell surface markers are not expressed in the embryo proper at E7.75, but there is a significant7 t) N  S4 V; p3 v1 n) n" g
reduction in CD41 (D) and CD34 (F) at E8.0. (E)Summary of multiple experiments comparing hemogenic and endothelial markers CD41 and CD34.
4 c0 w; C8 ]$ d4 M7 h  T**, P<0.01; *, P<0.05. Error bars indicate s.e.m. LPM, lateral plate mesoderm; CM, cardiac mesoderm; PM, paraxial mesoderm.+ q7 N1 S  e$ Q- ]
DEVELOPMENT(Fig. 4A). These transcriptome results for the EYFP–
$ {& \, b) a( ?cells support$ M: P* j2 {$ e" {: t% x
the notion that EYFP is not being expressed ectopically.6 g7 \( D9 h; Y& X1 T0 j
Furthermore, this indicated that there were no significant non-cell-
+ w' q8 {2 r5 F5 d3 eautonomous effects on gene expression resulting from the lack of
3 H, [6 v" Q8 `ER71 at this time point.! S( X" _9 w  D# \8 u' v
Within the EYFP+ populations, the Er71 mutant and wild-type
' o' [7 Q9 M! q/ R: Pcells were significantly different (Fig. 4A). A large number of2 ?1 B4 O9 m) w
hematopoietic and endothelial transcripts were decreased in/ T; d. A- {: `4 F4 \- ~
expression between  Er71 wild-type EYFP+ and  Er71 mutant
; G6 N5 k4 \, U) U% B9 |% ZEYFP+ cells (Fig. 4C). Importantly, ER71 expression was restricted8 z- u% o/ b" v0 `
to the EYFP+ cells in the wild-type background (Fig. 4C, arrow)," o6 x6 {$ g3 {( O3 ^8 D
confirming that the  Er71-EYFP transgenic model reflects( l. j% f" P6 ~! k
endogenous ER71 expression. Other transcripts that were( ^) [3 q$ W4 L! E4 x
downregulated in the mutant EYFP+ cells compared with the Er71
" m' J! i6 m3 U6 a3 R: Rwild-type EYFP+ cells included endothelial and hematopoietic# c" I! \8 W. P* X( s$ m3 x2 `! a+ A
transcripts such as Hbb-y, Fli1, Erg, Tal1, Cldn5, Cd93, Sox18,: g  B# c0 i; K
Cdh5, Sox7, Mmrn1, Eng and Nos3 (Fig. 4C). These data indicated6 n/ \. V! j7 r  ~5 |9 q
that the EYFP reporter-positive cells contributed to the endothelial
4 p/ I  Z2 \. h1 q; a$ Fand hematopoietic lineages and did not express markers of those/ G7 p6 }* W/ ~! Z; E) Z
lineages in the absence of ER71, consistent with the previously
' ^4 a$ a6 h* x) ~0 z3 ddescribed phenotypes (Ferdous et al., 2009; Lee et al., 2008).9 i# K! e8 P' i* |) \
Transcripts that were significantly upregulated in the Er71 mutant
) }* r  l* N8 eEYFP+ cells compared with the Er71 wild-type EYFP+ cells were% S6 S6 P( W0 p! m
associated with muscle lineages (Fig. 4B). These transcripts
! q7 G/ ?2 n4 T$ u/ j8 K) D5 aincluded Smarcd3, Myl3,  Irx4, Tnni1, Myl2 and Tbx5 (cardiac-" a- d) C3 d3 ]; ~" b
restricted transcripts); Acta1, Myl1, Svep1, Dpf3 and Cdo1 (skeletal
7 L( v, R7 F6 b$ ?  Amuscle-expressed transcripts); and  Acta2 and  Myl9 (vascular. f' _. I, h; R- B# i( M
smooth muscle-specific transcripts). These results suggested that
: e& \- S3 Y2 l3 k, A: `the EYFP+ cells gave rise to other mesodermal lineages in the
, n# ~' A* i+ c/ `1 n" iabsence of ER71.- A8 w7 n6 K- v& f: J9 x
In order to determine whether the cardiac lineage was broadly
) R- a4 f' U/ _3 Y' ^affected, we analyzed transcripts from the cardiac development& S6 h  _6 T1 X1 |
gene list in gene ontology (GO) terms and performed a hierarchical( y3 u, W7 y9 ]9 s; J0 ?$ N! T
clustering analysis. Similar to the results obtained from whole-
/ }4 O$ }6 e  g7 J: P8 x" Egenome analysis, wild-type EYFP+ cells segregated from the5 t" }6 i- q: q
mutant EYFP+ cells (and all EYFP–
2 K8 t  Z! ]+ R7 b" Ccells) (supplementary material
* ]; G; V& R3 e/ W$ {" UFig. S4A). This result demonstrated that the difference between' ?0 }5 e4 d9 p# w9 Y
these two populations can also be detected based only on cardiac# }+ C" M: L% c
development criteria. Some transcripts were decreased in EYFP+# Z1 r  b3 o6 R1 J3 \
Er71 mutant populations compared with EYFP+ wild-type cells,
, ?8 M5 m4 f" O* J" Hincluding a number of transcripts that are important for endocardial
5 J3 M% _$ N8 G& Jdevelopment (including  Eng,  Hhex,  Sox18,  Nfatc1,  Sox17)" v3 q: P) Y4 d: K
(supplementary material Fig. S4B). A number of transcripts were
2 o5 |* }8 u) ?, x* i' |increased in expression in the EYFP+ Er71 mutant population* A* H- N, L  z6 ^) x- E
compared with the other three groups (EYFP+ wild-type and both
4 ~) C9 s% |& c/ I) L) GEYFP–
/ j- S- p6 v9 G9 q9 {- f6 bpopulations), including a number of cardiac transcription; ?5 e2 D# W: C' w2 l
factors (Myocd, Nkx2-5, Irx4, Isl1, Gata6, Tbx20, Tbx5, Gata4,+ m- L# R/ `! \4 u4 `" K) i- C& m
Smyd1 and Srf) and structure-function transcripts (Myl2, Myh7,
, @# w( X5 S& N" tMyl3, Tnnc1, Tnnt2, Tnni3) (supplementary material Fig. S4C). We6 w7 k! E8 m; H8 e/ C* b0 ~. @" P0 Y& D
validated changes in selected transcripts by qPCR on independent
8 t7 X/ \7 Y. Q/ D2 K9 i, Rsamples and confirmed decreased expression of Er71, Tal1 and
- b$ Y( Z# Y1 k2 OCdh5 and the overexpression of cardiac transcripts including Nkx2-( T0 D0 ]$ \  \( \: B2 n2 B( X( Z
5, Gata4 and Tbx5 in Er71 mutant EYFP+ cells (Fig. 5).) Q1 i' O, S6 w* c$ t7 z3 r  T
In summary, our transcriptome analysis indicated that cardiac
* F- u/ S% a. i. R( ]genes are over-represented in Er71 mutant EYFP+ cells, whereas, i8 P+ E& X. M# B" P; F5 y6 i0 b
endothelial, endocardial and hematopoietic genes are under-0 ]2 O. A/ l$ R6 H
represented.% b: W1 _$ C7 q$ n4 x9 i8 Z) Y
A novel Er71-Cre transgene marks endothelial and
; a. W8 m% t9 ?' O; whematopoietic lineages+ R- }' \' n+ x: Z) E
In order to determine whether ER71-expressing cells give rise to0 _3 c( [4 I8 g3 [. [* T
organs or programs other than the endothelial and hematopoietic
  U+ m6 W' F6 T& a' Blineages, we generated an Er71-Cre transgenic mouse model (Fig.
0 h/ ^+ D# h$ C7 i, T) Y* L: D6A). We obtained a total of six founder lines, with embryos that, F$ i) R; J+ D" \, L
showed similar expression patterns after breeding with the Rosa-
+ H6 G* ]$ s0 |* {& M* `+ [4807 RESEARCH ARTICLE ER71 governs progenitor fates
' r% [1 u! n9 t: iFig. 4. Transcriptome analysis reveals that hemato-endothelial
* |: f/ K+ t2 j+ a9 Aand cardiac lineages are dysregulated in the Er71 mutant2 n& D9 r+ _: F' R
embryo. Transcriptome analysis was performed on EYFP+ and EYFP–
+ S* \, p. i) Y0 `$ k) }. L1 e! Rcells sorted from wild-type and Er71 mutant littermate mouse embryos.3 Y/ b/ [2 \; i8 J  b3 I
(A)Clustering analysis shows that wild-type and mutant EYFP–
& I# @6 W+ e& \3 wcells are- @  K" i- o* ?2 Y
indistinguishable, whereas EYFP+ cells from wild-type and mutant
  P# ~1 e; V) A1 rembryos show distinct gene expression profiles. (B)Transcripts6 m7 M$ O$ B8 I; _- K" S+ h  m
upregulated in the EYFP+ mutant progenitors include cardiac and6 e* U& X% |, {7 k
skeletal muscle genes. (C)Downregulated transcripts in the Er71
/ J! i/ N! }# o% R2 ~mutant background include hemato-endothelial transcripts, including
: S! J+ t$ V, [* T; Q/ r6 T( LEr71 (Etv2) (arrow).: r: ^- s6 D% a5 X9 ]: N: f, R6 K5 g
DEVELOPMENT4808) m; @! G  O! e
lacZ reporter mice (supplementary material Fig. S5). Two1 G# E' Z9 E  k2 e5 V' s
transgenic lines were crossed to the Rosa-EYFP reporter mice and* V5 `  U/ h0 {( G& D! N; {% O
used for immunohistochemical and FACS analyses. Our results0 o0 @' s1 S1 Q' N
revealed that E11.5 embryos were marked by Rosa-EYFP or Rosa-
0 c$ L# A( e5 l* w9 nlacZ in the endocardium, cardiac cushions, vasculature,& h- ^% \& S9 s  w
mesenchyme and the fetal liver, which is the stage-appropriate site
2 W1 j9 P0 V8 v2 W* a" Y8 yof hematopoiesis (Fig. 6B; supplementary material Fig. S5G,H;7 e) e) ]5 m' r) u1 q$ U; {
data not shown). Hearts of P3 neonates were marked by Rosa-
. ?2 E  [% e" v6 R" p0 U3 P; rEYFP in the vascular structures (Fig. 6C). Co-staining for EYFP1 ~# w" c/ F5 e
and desmin, an early muscle-specific structural protein, showed. A& V* R' ?: L9 l2 D' z! @9 b/ n
that the Rosa-EYFP reporter did not overlap with desmin staining, ^% a9 Y5 ]: }4 v1 c/ b1 Z7 r# K
in the heart at either time point (Fig. 6B,C). FACS analysis of
" b% @; ?" m3 b, Twhole E11.5 embryos showed that 7-8% of cells in the E11.5! e( [" Q8 |# M4 ^
embryo were derived from ER71-expressing cells (Fig. 6D,E). Of
6 f: [7 w$ K# r; tthese EYFP+ cells, ~12% were endothelial (CD45–2 J& {( K) L1 @# S% G  ~$ L
CD41–
6 S' R7 z* @9 ], y/ E, s" GTie2+;. a+ W; w% m; A3 o2 u5 J
Fig. 6F), 23% were non-erythroid hematopoietic cells (CD45+, also
0 e6 T2 I3 v7 Z3 _0 g% F2 yRESEARCH ARTICLE Development 138 (21)( s6 J2 C2 J1 K0 F. W; ]# f
Fig. 5. Representative transcripts from the cardiac program are overexpressed in the Er71 mutant. (A-F)qPCR analysis was performed on
. [! p0 H6 [0 h6 @/ P2 P$ \RNA isolated from EYFP+ cells in the wild-type (embryos 1 and 2) and mutant (embryos 3 and 4) backgrounds. We observed the loss of Er71 (A),: ?* {: G& P7 e- U0 A: s; ]
Cdh5 (B) and Scl (C) expression and an increase in the expression of representative cardiac program transcripts including Nkx2-5 (D), Tbx5 (E), and
  A+ f' J% a$ }6 l4 lGata4 (F). Error bars indicate s.e.m.
" [& C) a+ `: }/ U' WFig. 6. Genetic fate-mapping studies indicate that ER71-expressing cells give rise to the endothelial and hematopoietic lineages.
' c+ o0 d9 `5 M: o% E; ~1 s(A)The transgenic Er71-Cre mouse model used for these studies. (B,C)Immunohistochemistry for GFP (green) and desmin (red) and DAPI staining
+ t  |3 j# x! p- o1 n* F1 ?+ X; D(blue) in E11.5 (B) and P3 (C) heart. a, atria; bw, body wall; cu, cardiac cushion; fl, fetal liver; v, ventricle. (D)A representative FACS profile showing3 C, H9 J. N8 R5 g4 @
EYFP+ versus side scatter width (SSW). (E)ercentage of Rosa-EYFP+ cells from all experiments (n9). (F-H)EYFP-positive cells were gated and
0 u9 l: g. `; j) fanalyzed for lineage contribution. Representative FACS profiles are shown for (F) endothelial lineage (CD41–, m  A2 B% I# ]: J( M
CD45–5 h% Z# t3 U# I0 b' E- z4 l
Tie2+) cells and (G) CD41+; u& z: s& l5 D6 G3 q3 Z  n7 x
CD45+, (H) CD45+ Ter119–: C+ v& \7 e) k! c; F: Z
and Ter119+ CD45–( [) O  }) _# n2 A, ]& X0 b0 N
hematopoietic lineage cells. (I)ercentage of Rosa-EYFP+ cells of each lineage from all experiments
$ ]  O- o$ J" O; u: t6 P(n9). Error bars indicate s.e.m. DEVELOPMENTknown as Ptprc; Fig. 6H), and 13% were erythroid (Ter119+; also
$ g  {4 }; |2 Y1 bknown as Ly76; Fig. 6H). Interestingly, the EYFP+ population* a* K% s) ?9 M0 @7 Z
segregated into two populations of varying EYFP expression (Fig.. a. o% M! b$ w2 O' x& k9 o
6D). Ter119 primarily marked the EYFP-low population, whereas
" z* u9 Q4 X* Z7 o2 b5 b: _; qendothelial and other hematopoietic markers primarily marked the  b5 j, u7 X5 [3 \, y
EYFP-high population (data not shown). This suggests that the
2 v5 `) u1 o% W  B; a6 j( ARosa reporters are expressed weakly in erythroid cells and might  d6 R! T5 [, O; \4 x2 z* g' W
therefore inefficiently mark this population.2 E/ Q1 J. a; k: f6 s% P) U
ER71-EYFP-expressing cells give rise to6 {" F* ^6 \' D: }" C
myocardium in the Er71 mutant
: u0 ~4 p7 s! P& i! ~1 yTo determine whether ER71 reporter-positive cells could produce. G' U& M  }3 B9 P4 P3 j6 y! K7 k9 Q' ^
alternative lineages in the Er71 mutant, we crossed the Er71-Cre' W6 O$ e6 p! r4 |$ T9 @
and  Rosa-EYFP alleles into the  Er71 mutant background. As
5 F4 ~7 T' r/ Wobserved with the ER71-EYFP reporter, Er71 mutants carrying the1 b: L4 t4 z( x$ [7 ^3 I- K5 B; B
Er71-Cre and  Rosa-EYFP alleles displayed altered EYFP
; q- ?/ p  B7 oexpression patterns. Compared with the Er71 wild-type embryos at
* H" n. T0 G: c/ e9 _# ?E8.0, in which Rosa-EYFP is expressed in the yolk sac, vessels and% h8 U, i' q4 C. i  Z- Z
heart tube (Fig. 7A), the Er71 mutant embryos had robust EYFP
, W! F2 M8 u! Jexpression localized in the allantois, posterior mesoderm and: t9 @- U2 a/ {% U+ g
paraxial mesoderm (Fig. 7F). We speculate that the increased+ i) [7 B! q/ L- s) T$ S, k5 o' h
expression in the allantois and the posterior mesoderm is due to the- F! j# I$ ?/ U/ ]  b8 _
progenitor cells differentiating to alternative mesodermal lineages,
0 V/ c3 K& t! O1 b* operturbed migration patterns, or a combination of the two. Embryos
& _, Z$ ?% M' e/ \were analyzed using immunohistochemical techniques for co-/ |* y$ C7 n& p' s5 ]" e
expression of EYFP and Nkx2-5, a cardiac transcription factor,
% f" }! }6 e, r, Y2 pEYFP and desmin, or EYFP and troponin T, a cardiac sarcomeric1 J6 t7 U  l1 A* i
protein. In wild-type hearts at E8.0, EYFP was expressed in the
+ c/ E" `: R" w8 @* I  q7 N  Eendocardium, the major vessels such as the dorsal aortae and in  l2 k# p. W' k* M7 c
hematopoietic cells within the heart (Fig. 7B-E). There was no6 U1 }. g: z) s" T$ A; m" v
overlap of EYFP expression with Nkx2-5, desmin or troponin T.) O5 O3 E5 b  A( d
In the Er71 mutant embryo, the vessels and endocardium were& \( T1 Q3 D/ R* g7 g+ Y
absent. However, EYFP expression persisted in the heart. In the$ k) `) H* N: E4 C( r/ C
heart of the Er71 mutant embryo, all EYFP-expressing cells had an& o6 f& r1 b* W2 j
Nkx2-5-positive nucleus (Fig. 7G,H). Some of the EYFP-
7 |& j% B2 @  R% |expressing cells were also positive for the structural proteins
. o; W5 M# f7 k2 \7 _; Wdesmin and troponin T (Fig. 7I,J, arrows). These results support the: y% ]; x8 l9 X0 R: ]" {# z, A
notion that the EYFP+ cells are capable of differentiating to the
- D- b% ?, F8 H$ qmyocardial lineage in the absence of ER71. It is likely that" U; m7 I, k4 o
progenitor cell populations are also capable of differentiating) j+ e/ _  m) F- d+ K& I7 D. R
toward other lineages depending on the context of the spatial and
8 Z6 r6 D  Z9 I$ |  |- p; C' jtemporal cues that they are exposed to during embryogenesis.
/ A$ C5 w7 M( E" v3 ^  |# RHowever, the heart is one of the few organs present at E8.0 and: H8 Z& s* R0 x1 v
Er71 mutant embryos are nonviable by E9.5. Therefore, the
' q$ F% K% _+ Llethality of the  Er71 mutant limits our ability to evaluate the! b  j9 t2 ]# Y, j, v4 c. ]
contribution of EYFP+ progenitors to other lineages that develop
! y3 c8 R+ @3 K8 R% Z7 Klater during embryogenesis.+ U% h: W0 j! |
ER71 overexpression suppresses development of! E* v: z/ |' C& r* w
the cardiac lineage
' G9 h  a  {8 x, H( }To complement our analysis of the  Er71 mutant embryo, we
" L: y/ E0 a) S3 Woverexpressed ER71 using a doxycycline-inducible embryonic
2 G3 e: n9 t. o6 N- Y, estem cell (ES)/EB system. An ES cell line in which expression of
$ ]5 Q9 {& e0 QER71 can be induced by doxycycline treatment was generated by
6 R; `! E6 B8 L. z. Ka cassette exchange method (Iacovino et al., 2009). ES cells were4 t, W% ~" `" q/ x
induced to form EBs in differentiation media and cultured for 10
$ _7 Z* B6 {7 K5 d% \days with or without 0.5 mg/ml doxycycline from day 3. In the: A* p# H' f1 n4 n& T
ER71-overexpressing EBs, we observed a decrease in the& W8 ~# Z. s. M/ P
expression of troponin T, which we quantified by comparing the
1 w9 u0 k. N! ]6 Ipositively stained area with the total area of the EB (Fig. 8A-E)./ X# N/ b& @1 x7 j  {
We also observed a decrease in cardiac gene expression (Nkx2-5,  k1 l8 ^; Z* j1 V- r5 e
Tbx5 and  Gata4), as quantified by qPCR analyses (Fig. 8F).
8 K  k* e9 h# ~  O) X- ~. }8 `) CFinally, we quantitated the ability of the EBs to beat with edge
. l( u" N1 B  V: J0 ^9 A. }: ^/ ydetection. The doxycycline-induced EBs had a dramatic reduction
& S1 ~" E2 o/ [/ n# U. `in contractility (Fig. 8G) and in percent shortening (Fig. 8H).
( g+ _( h1 _$ L' X! V& c6 w: Q3 tCollectively, these results further support the notion that ER71
# y5 {) B' j  O' H1 ssuppresses the myocardial fate of mesodermal progenitors.
; l3 ]  ^# B( i; }* S4 cDISCUSSION
/ A' Z2 z9 {4 Y+ h! F$ yAn array of signaling cascades and networks govern the fate of
6 W- `! h9 E" m6 h; tprogenitor cell populations and their contribution to mesodermal
4 f, p% l4 E) M4 V# Glineages during embryogenesis. Recent studies have demonstrated1 R* F0 C, e+ U' S1 A; C
4809 RESEARCH ARTICLE ER71 governs progenitor fates
* b  d: K1 C+ r$ W9 ^Fig. 7. Genetic fate-mapping studies in the Er71 mutant show that the affected lineages give rise to myocardium in vivo. (A,F)Whole-! L/ H# \. W; i& o1 ~: W% C0 ~& K, U+ u
mount images of Rosa-EYFP expression in Er71 wild-type (A) and mutant (F) mouse embryos. The red line indicates the plane of sectioning for the3 M3 q- B. z& v9 v
corresponding panels. (B,C,G,H) Immunohistochemical analysis of EYFP and Nkx2-5 shown at low (B,G) and high (C,H) magnification. (D,E,I,J)
2 K# A9 j3 @2 [7 V. [Immunohistochemical analysis of EYFP and desmin (D,I) or troponin T (E,J) expression. ys, yolk sac; h, heart; al, allantois; da, dorsal aortae; ec,
) I  T- V4 I% M' S  _- Qendocardium; mc, myocardium. Arrowheads indicate EYFP colocalization with desmin or troponin T. Scale bars: 200m in A,F; 20m in B-E,G-J.. D4 u4 D, L  n% i  B+ F
DEVELOPMENT48104 A/ q/ c/ o- {9 }$ {; V
that various progenitors give rise to multiple mesodermal lineages.$ {1 }  T0 J% U) I) F/ L
This broad developmental capacity is evident from the fact that
, f' w, C& O# ^multipotent progenitors have been shown to differentiate to diverse; E' Z+ i3 g& g
lineages, including hematopoietic, endothelial, cardiomyocyte and  X7 P9 j2 t4 A; C0 J
smooth muscle lineages. We have previously demonstrated that
" P# E6 l8 T8 t& \5 f& AER71, a member of the Ets transcription factor family, is essential. l/ C! N. d6 N$ v8 U6 Y2 e, P; \
for the development of mesodermal lineages. Er71 mutant embryos
+ ]# H: ?5 M3 O2 C% q3 ?9 Qlack hematopoietic and vascular lineages and are nonviable. Here,
) D- k$ X2 O" Q1 j! }; Cwe have further defined the role of ER71 during mesodermal
& y5 `/ A3 Y0 t% \, K% a+ W$ zpatterning and have made three new discoveries that advance our+ z5 O, x( N+ e0 q$ X3 ^  h) I+ O
mechanistic understanding of mesodermal fate decisions during& O& j% V7 ~& A( N" S3 b, H
development.
# v4 p8 y; b" ?- W4 R6 BFirst, we have defined the expression pattern of ER71 during
7 D( o3 ~& o8 Pembryogenesis using a newly generated transgenic reporter
9 d2 J5 Q( M! n1 W. rmouse model. Using immunohistochemical techniques, we, Q& r/ Z( b1 o6 v
demonstrated that ER71 is largely co-expressed with Tie2 in! @5 H0 G( J" h  f! Y
endothelial and hematopoietic progenitors. In the absence of% T# c. D' D: B# B
ER71, we observed that these progenitors are expanded in" y1 {9 e# N0 U, e1 I7 h* Q
number but do not represent the hematopoietic and endothelial
8 f2 U/ A( y& I4 Slineages; rather, they are redirected to other mesodermal
  L+ c' D4 h& z. G, }/ M. zlineages, including the cardiac lineage. These data also show that
9 W( h; h3 l8 p! a0 V/ M- P- YER71 is not required for the initiation or maintenance of its own
1 i* T0 o4 f7 S3 H: gexpression. In the absence of ER71, this increase in the number
! H# G# X$ f: |of progenitors (EYFP+ cells) might represent a delay in cell( C0 z2 N+ V! q0 m
cycle withdrawal due to the lack of distinct mesodermal lineages
; B! b2 K9 i4 [8 R- ]& i: }(i.e. hematopoietic and endothelial lineages) or, alternatively,( S: S, O- ^# t7 Q, k
decreased programmed cell death involving these progenitors.3 N% H3 F3 n6 g: p6 ]9 k: s& Y% F( A
We did not observe an increase in apoptosis in the Er71 mutant
5 I$ }( C3 B( z6 n+ @  Rembryo compared with its wild-type littermate control (Ferdous
5 j7 `& @( d$ a; met al., 2009). Thus, we hypothesize that the progenitor cell. |- j' k! x" X1 @) q$ t9 {& x
expansion in the absence of ER71 is a result of the lack of& Z( C( S. `+ s3 a$ A
cellular differentiation to hemato-endothelial lineages.
8 U! ^  ~6 c* n- AOur second discovery defined the fate of the ER71 progenitors) h  _* V( j5 D% A  B1 m' S
in the presence and absence of ER71. Using genetic fate-mapping
6 e& Q& i3 r; z8 l( H& Kstrategies, FACS and whole-genome analysis, we demonstrated that+ ]  ~6 K1 E: x2 I, x% l% R
ER71 progenitors give rise to hematopoietic, endothelial and2 r2 u  R0 S6 R# x! `0 v# E/ z7 A
mesenchymal lineages. In the  Er71 mutant background, these4 H4 O8 [2 J* Z2 U6 B0 H3 B
progenitors (EYFP+ cells) produced other mesodermal lineages,
2 f, M' b7 c' w. v( uincluding the cardiomyocyte lineage (supplementary material Fig.
, c3 @2 n. p. LS6). Moreover, our FACS and transcriptome data supported the6 L2 Q, {# v$ b5 \( c
notion that paraxial mesodermal programs (transcripts enriched in# k7 o6 ]$ I; X# Q3 l
the skeletal muscle lineage) were increased in the Er71 mutant8 x- ~, ^1 G5 q+ |# ]: Q
progenitors. Accumulating evidence suggests that the cardiac and
/ `5 w' G  i# F6 w( e& Qhematopoietic lineages develop from a common progenitor and that
, t" R6 B6 m4 S% x& H- Q. g! Jthe specification of these lineages is inversely regulated. We0 r2 R# M0 f2 y
recently demonstrated that Nkx2-5 has a dual transcriptional
: i$ ^, }, J2 t) a& `regulatory role during embryogenesis as it represses Gata1-4 N0 T" Z% }$ i. U8 j' u- E
mediated hematopoiesis and promotes cardiogenesis of the
0 A% m4 q$ E" ]1 F' C* tmultipotent mesodermal progenitors (Caprioli et al., 2011). The# F3 L& N" l. F. g- [
results of the present study further support the plasticity of the4 D" u! O  G1 f$ x8 @: ~
ER71 progenitors and their capacity to respond to cues and
, l3 [+ z# v$ h. O1 U% Kcontribute to other mesodermal lineages.
+ I% H/ Z. }4 @) a# t" dThe origin of endocardium relative to the myocardium has
9 T& |: t: C$ ]4 f! wbeen controversial (Harris and Black, 2010). Studies in zebrafish7 x7 b7 {( y" b# k0 _
and chick suggest that endocardial and myocardial lineages are! _7 P6 g2 b+ X5 T4 l( W3 {
distinct from the point of gastrulation, and there are no+ g  Z! I$ D% F8 x
multipotent progenitors (Cohen-Gould and Mikawa, 1996; Wei; M; E) r. _3 m4 c
and Mikawa, 2000). By contrast, lineage-tracing studies in3 I* h, |+ i+ _4 X5 b
mouse embryos and ES cells suggest that endocardial7 w; r8 t8 ]3 v6 t; w
progenitors are specified as multipotent progenitors in the* Q5 w+ M: C2 L
cardiac crescent and cell fate is later specified to either
4 P" c4 y) h8 k9 |6 z. Mendocardial, myocardial or vascular smooth muscle fates
* `3 {. |2 K1 Y2 G8 R(Kattman et al., 2006; Misfeldt et al., 2009). In our novel ER71-: \% V7 `. U4 Y2 x% t1 z, K' ]
EYFP reporter mice, we observed weak co-expression of Nkx2-
$ \( p) _! G3 c5 protein and EYFP in the cardiac crescent at E7.75. However,, h2 Y, j9 c" n
lineage-tracing experiments showed that cells that expressed2 [8 A/ Y( K6 W# w" B+ T4 K
ER71 during any point in their development did not become
2 E# P; F  j8 S2 y7 dcardiomyocytes. By contrast, Nkx2-5-Cre lineage-tracing( o% H, j5 B) ^  W& U2 L
experiments show that at least some of the endocardial lineage6 q/ I  O2 m) k# _
derives from cells that expressed Nkx2-5 (Stanley et al., 2002).
) p$ q1 S( g  \& A/ @* L& QTaken together, these observations favor a model in which$ e( ]' B" T  P
common progenitors of endocardial and myocardial lineages are8 W) K1 x/ }/ c; Y( R  o0 \8 S
specified as Nkx2-5+ cells in the cardiac crescent, but those that
. d$ {; ?  r6 R- W, @% GRESEARCH ARTICLE Development 138 (21)% N3 l, b2 b: U% t$ u
Fig. 8. Overexpression of ER71 in differentiating EBs inhibits
0 J- {1 e- L1 _" o9 s2 ecardiac development. (A-D)Sections of representative EBs either
; F" i4 J3 j( j- n' |# ^" Juntreated (A,C) or induced to overexpress ER71 (B,D) stained with
" E6 B$ `1 }& t! y6 q$ J" qHematoxylin and Eosin (C,D) or anti-TnT (A,B). (E)Quantitative analysis of
$ U: ~  G  W0 wthe troponin T-positive area in 33 induced (Dox) and 42 untreated) c  a' ]" F8 ^# J+ ]' W
sections. (F)qRT-PCR confirms that representative cardiac program8 l( [7 U. I) ~  F
transcripts (Nkx2-5, Tbx5, Gata4) are downregulated in ER71-
. `6 ^* ~' T/ L' r7 Aoverexpressing EBs. (G,H)Extent of contraction and relaxation after 2: {) y  N( ~3 h& U
seconds of stimulation (G) and percent shortening (H) are reduced in. q7 [  ^( E) w4 U9 F; ~, T
ER71-overexpressing EBs. ****, P<0.001; *, P<0.05. Error bars indicate4 s6 H- ]* g! c: o
s.e.m.
# T" r) Y0 [9 Y. cDEVELOPMENTwill become endocardium will downregulate myocardial
. b% }1 {4 x+ H. gpotential, including the expression of Nkx2-5. Once ER71 is
2 `$ N/ ^2 n) @4 q  m% M  Hexpressed, the fate is restricted to endocardium, and not4 ]1 L6 h- b& {* o# b
myocardial lineages. Future studies are warranted to decipher the6 W, D: J0 `- x. U$ @4 U
mechanism that governs the specification of endocardial cells; l/ B  }+ K, C' N
within the cardiac progenitor pool.: ]! ?: o, r5 T/ i3 c( L6 X# p! Y
Our third finding is that ER71 overexpression repressed cardiac
' r1 k6 w1 S+ w9 k: e* v; F4 Xpotential. These results support the notion that ER71, like Nkx2-5,
! G. Q8 T7 ]. `# i8 X( o9 ~9 rhas reciprocal and overlapping dual roles in the specification of4 G9 @  E% }' C) K
mesodermal lineages. Our previous studies demonstrated that
1 P9 H  I. |- u; B  |Nkx2-5 overexpression suppressed hematopoiesis, but not the9 T5 _* h4 G5 |0 p* X
endothelial program (Caprioli et al., 2011). We further defined that
3 S8 o( Y9 Z- XNkx2-5 could, in a context-dependent fashion, transcriptionally( y" S/ \' z- C9 U& L
activate  Er71 and promote endocardial lineage development/ X( Z5 x$ V) T6 ]- ?8 X) T
(Ferdous et al., 2009). Collectively, our previous studies and recent
. u- R. {1 M, `; rresults support the notion that distinct transcriptional networks can,
( `9 f9 F3 N- |; E; rin a context-dependent fashion (and dependent on the local: c6 i9 ^' [2 ~: s5 H- ?7 N6 c
environment), activate a hematopoietic or endothelial program and* h  g/ H5 @* {8 P8 N$ t. W
antagonize the cardiac program. These studies further emphasize8 a0 b: h% f% h* h6 ~3 _
the plasticity of progenitors and their contribution to distinct
4 x; V; c" X+ Hlineages.3 j$ x8 h3 r7 h3 o( M* G
In summary, our data support a dual role for ER71 in the- a5 C2 _  D+ l* t2 w
specification of the endothelial and hematopoietic lineages and the
; X$ l! |9 P9 e: Y1 lsuppression of other lineages (i.e. myocardial and paraxial, b8 H1 t& C. G+ G# w4 G, D' M
mesodermal cell fates) (supplementary material Fig. S6). Our
8 [3 n" Y- d6 \7 ^, ?! g3 zstudies further support the notion of multipotent mesodermal
* v% M5 p, g  d% a0 f; {. rprogenitors that are dependent on transcriptional cascades and other( T8 W0 [. d6 Z: F  {! p: ~
cues to direct them to populate one or more lineages. Moreover,
5 p' ^9 d: `, ]7 ]+ X! iour studies reveal that global deletion of a single gene (i.e. Er71)
' L) u) r: n& U8 x8 Daborts one or more lineages and redirects the cells to other lineages
% I3 U) E0 b. z, e( n& Athat would not typically arise from those progenitors. These studies
/ R! U8 g1 `  J% x; }8 f! h" m9 lfurther our understanding of the regulatory mechanisms that govern0 O; ^5 ^, N: `& \0 Y1 F
mesodermal cell fate decisions and embryogenesis.2 j0 P; Z* S, G( n, f
Acknowledgements
6 h4 ~* ]$ K6 }" [, AWe thank Jennifer L. Springsteen and Alicia M. Wallis for assistance with6 O2 ~3 y3 s+ _, i- d( F) t
histological analyses and animal care.6 M7 @; N* O3 |3 e2 d8 D; o
Funding3 t+ I. b0 `. w1 u! A/ u
Funding support was obtained from the National Institutes of Health [U01
9 c: V0 R2 a( Z; g+ IHL100407 and R01 HL085729 to D.J.G.]; and the American Heart Association) t  I$ f  L- l( i+ G# k
[Jon Holden DeHaan Foundation 0970499 to D.J.G.]. Deposited in PMC for
0 s$ U8 b+ @: `release after 12 months.1 A. m  a' u+ c' D2 _
Competing interests statement" X& v& p8 \- N1 |
The authors declare no competing financial interests.
9 K0 J0 B& k4 CSupplementary material% s( d8 W: q( z
Supplementary material available online at
% \$ ^$ P& l3 d* m$ ?http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.070912/-/DC1) H8 d6 {) Z' D: h: w! W- H# R
References" D0 b8 Z# K4 i3 g9 c$ W' a
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a5 t- @/ Q; R2 t" F1 }  |/ M8 e
practical and powerful approach to multiple testing. J. R. Statist. Soc. B 97, 289-
( o; }: w( g1 E3 i2 o2 Z$ l300.# P' r, n$ U7 n- {' D
Bondue, A., Tannler, S., Chiapparo, G., Chabab, S., Ramialison, M.,5 i5 Y9 I: d5 s8 H' c. c& W$ E
Paulissen, C., Beck, B., Harvey, R. and Blanpain, C. (2011). Defining the/ Q1 |! F: O+ l
earliest step of cardiovascular progenitor specification during embryonic stem3 S3 V6 L, W' @: Q0 b
cell differentiation. J. Cell Biol. 192, 751-765.
0 c3 [2 B% w; g: e0 ~Caprioli, A., Koyano-Nakagawa, N., Iacovino, M., Shi, X., Ferdous, A.,
; Z& d( l" A; hHarvey, R. P., Olson, E. N., Kyba, M. and Garry, D. J. (2011). Nkx2-5
& u- Z' S5 R2 f; u' i4 x$ m" U4 ]$ frepresses Gata1 gene expression and modulates the cellular fate of cardiac
) `) _0 p$ b% fprogenitors during embryogenesis. Circulation 123, 1633-1641.
5 M- P2 I! V, ^& zCarbon, S., Ireland, A., Mungall, C. J., Shu, S., Marshall, B. and Lewis, S.' K$ x' D! M" H5 X
(2009). AmiGO: online access to ontology and annotation data. Bioinformatics
+ e) B* I4 j/ h$ n: W' j25, 288-289.+ F, ~) n2 o; P4 B( C) J
Cohen-Gould, L. and Mikawa, T. (1996). The fate diversity of mesodermal cells) i+ D6 \4 S& X. c3 a
within the heart field during chicken early embryogenesis. Dev. Biol. 177, 265-9 I% D+ |# `( g% k9 o2 |3 f/ x5 p
273.
" n& b9 ~# N7 i$ h5 y6 L) w2 KDavis, L. A. and Zur Nieden, N. I. (2008). Mesodermal fate decisions of a stem
2 h. a6 v6 m; ]6 k+ j! X. `cell: the Wnt switch. Cell Mol. Life Sci. 65, 2658-2674.
2 G; O. q& |. o0 E/ Ade Hoon, M. J., Imoto, S., Nolan, J. and Miyano, S. (2004). Open source: a3 k5 V( s+ J% p
clustering software. Bioinformatics 20, 1453-1454.9 ?2 `: @- v$ y$ r9 [( R2 x
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris,
8 F9 N8 [9 Q/ R2 W" ^I. S., Ehlers, M. L., Agarwal, P., Visel, A., Xu, S. M. et al. (2008).( J' ]0 H- v( ^
Combinatorial regulation of endothelial gene expression by ets and forkhead
# K2 r0 T6 y& |4 htranscription factors. Cell 135, 1053-1064.
+ \2 S6 r+ k$ ~0 S0 Z, s" U: g. ODowns, K. M. and Davies, T. (1993). Staging of gastrulating mouse embryos by
- A) J- j" L! x/ J+ v# \morphological landmarks in the dissecting microscope. Development 118, 1255-  d2 y0 g! ?2 @) F
1266.
5 E+ u9 ^  y8 q' r7 M3 ~2 hDumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J. and Breitman, M.
  L+ X6 o$ T5 _4 l( v' rL. (1992). tek, a novel tyrosine kinase gene located on mouse chromosome 4, is
6 z$ O+ V# D7 ]8 V6 Cexpressed in endothelial cells and their presumptive precursors. Oncogene 7,
; A* e( D2 f, g/ \0 G1471-1480.2 U% A' g2 E6 F$ B4 q1 B
Ema, M., Takahashi, S. and Rossant, J. (2006a). Deletion of the selection
" D3 k# Y7 n& q) d3 \, U) ycassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk1/ t. U1 `/ m3 d
expression in multipotent mesodermal progenitors. Blood 107, 111-117.
  m+ j: l1 m4 l& ~Ema, M., Yokomizo, T., Wakamatsu, A., Terunuma, T., Yamamoto, M. and
* P4 b* P4 H+ Z. @( mTakahashi, S. (2006b). Primitive erythropoiesis from mesodermal precursors
, V# H  E7 W& z2 ~' b9 z. Texpressing VE-cadherin, PECAM-1, Tie2, endoglin and CD34 in the mouse9 J, O" @6 p8 P
embryo. Blood 108, 4018-4024.
8 a  |/ g4 |  B" M. Y+ r1 x8 zFerdous, A., Caprioli, A., Iacovino, M., Martin, C. M., Morris, J., Richardson,+ p6 `2 K( ~9 H' N) U1 p
J. A., Latif, S., Hammer, R. E., Harvey, R. P., Olson, E. N. et al. (2009). Nkx2-
- k+ e0 A% u- V& z; b3 S4 s5 transactivates the Ets-related protein 71 gene and specifies an endothelial/: c% G& A, ?7 Y* R3 f7 v/ w& x
endocardial fate in the developing embryo. Proc. Natl. Acad. Sci. USA 106, / L% Q# I" V* `: [. z
814-819.  \  l5 ~, H; |" c( h1 H' m% K+ N
Harris, I. S. and Black, B. L. (2010). Development of the endocardium. Pediatr.
* ?; i4 l3 n- S7 K  J! a. ?Cardiol. 31, 391-399.2 }: H+ E8 H( h. b
Iacovino, M., Hernandez, C., Xu, Z., Bajwa, G., Prather, M. and Kyba, M.
( m0 `" @- y) E' ]  S(2009). A conserved role for Hox paralog group 4 in regulation of hematopoietic
6 G: X# M" D8 v4 j4 Iprogenitors. Stem Cells Dev. 18, 783-792.
( M! Q( j, _; S( [# }9 EIrizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J.,6 m/ R( {# [% E/ m
Scherf, U. and Speed, T. P. (2003). Exploration, normalization and summaries* \, S0 H1 e2 r" b
of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.. L% c$ J9 ~6 h) X& ]
Ivey, K. N., Muth, A., Arnold, J., King, F. W., Yeh, R. F., Fish, J. E., Hsiao, E. C.,
; g5 j0 z0 n' b+ OSchwartz, R. J., Conklin, B. R., Bernstein, H. S. et al. (2008). MicroRNA
) [$ J, h5 s/ _8 r. c: Lregulation of cell lineages in mouse and human embryonic stem cells. Cell Stem: ]% A: p; U( T7 Q' N% \& V
Cell 2, 219-229.
* O+ R5 U& \/ k& VKataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama, H.,
) h. y2 u( u4 }. xKunisada, T., Risau, W., Kita, T. and Nishikawa, S. I. (1997). Expressions of1 D+ O9 R- N# y: f4 B6 n: J4 J
PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5, T* J* `, o  o/ L/ m
define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 39, 729-
% E  r5 n- T; L740.
2 F$ ^& w! w+ m6 r+ R* S3 X+ GKattman, S. J., Huber, T. L. and Keller, G. M. (2006). Multipotent flk-1+% r& F. }; a" k( I# U2 B# X% ~% ?- c
cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial and) M1 E6 ^  t+ X) m
vascular smooth muscle lineages. Dev. Cell 11, 723-732.
7 [* S6 J4 D' e8 E, nKaufman, M. H. (1992). The Atlas of Mouse Development. London: Academic
4 G4 E8 ]1 ^! y6 C9 c+ x1 rPress.
0 b" `- s5 P. x5 X" oKennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N. and4 e* g1 u7 h, _, t. W
Keller, G. (1997). A common precursor for primitive erythropoiesis and
% o- X3 Q) S- u" h9 Ddefinitive haematopoiesis. Nature 386, 488-493.
( Z8 g2 T  E  \1 ]; {Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson, J. A.
( o0 P' _: T7 k/ Y' B+ E1 Land Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for: Y5 j) y  J* Z6 W$ k0 }/ m% Y
endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.0 U$ `1 T  e5 R- n
Lee, D., Park, C., Lee, H., Lugus, J. J., Kim, S. H., Arentson, E., Chung, Y. S.,
4 Q$ Y1 {- g; P& Y# z, [Gomez, G., Kyba, M., Lin, S. et al. (2008). ER71 acts downstream of BMP,4 a* L' n5 j6 h! C9 E" U
Notch and Wnt signaling in blood and vessel progenitor specification. Cell Stem8 z. {, |  h2 W, ~$ R( p& V
Cell 2, 497-507.4 m% i9 S4 M% j* W
Li, W., Ferkowicz, M. J., Johnson, S. A., Shelley, W. C. and Yoder, M. C.0 ~* Z2 D. s" e- W9 T
(2005). Endothelial cells in the early murine yolk sac give rise to CD41-expressing
. H) d) b- V% Q2 Rhematopoietic cells. Stem Cells Dev. 14, 44-54.
; x# e" d1 M1 y- mMisfeldt, A. M., Boyle, S. C., Tompkins, K. L., Bautch, V. L., Labosky, P. A. and
& Q& ~! ?8 r1 v" J8 P2 N. Y+ IBaldwin, H. S. (2009). Endocardial cells are a distinct endothelial lineage( V9 y2 |' q/ `! H9 o4 y+ A+ V2 p
derived from Flk1+ multipotent cardiovascular progenitors. Dev. Biol. 333, 78-7 q2 G+ {: @/ j0 C! @
89.
& I. j  i7 a  a' D- [/ Z) bMoretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y.,3 f( Z1 n9 t& W
Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S. et al. (2006). Multipotent
; X9 N# U/ e4 Wembryonic isl1+ progenitor cells lead to cardiac, smooth muscle and endothelial
. f/ }6 \1 T$ k7 f: \% {; r# icell diversification. Cell 127, 1151-1165.
6 u5 y3 p! W! iMotoike, T., Markham, D. W., Rossant, J. and Sato, T. N. (2003). Evidence for- a! X' R7 K# C- f- j; U$ O) U2 \7 }
novel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis 35, 153-
, K9 c0 @8 @! t+ v159.
" x0 a2 F# P) [: {! vOmelyanchuk, N., Orlovskaya, I. A., Schraufstatter, I. U. and Khaldoyanidi,0 a( `% o# J$ j" p: L! G
S. K. (2009). Key players in the gene networks guiding ESCs toward mesoderm.
2 Z+ B1 A+ S% C6 Y! y+ UJ. Stem Cells 4, 147-160.
( u9 w- h4 f+ |- I, }Park, M., Yaich, L. E. and Bodmer, R. (1998). Mesodermal cell fate decisions in0 y. V0 @4 s5 l8 p& v
Drosophila are under the control of the lineage genes numb, Notch and
0 ?4 u% ^" o% a, f$ i% y: gsanpodo. Mech. Dev. 75, 117-126.
) a: t8 E1 I& t# Z. ~) F4811 RESEARCH ARTICLE ER71 governs progenitor fates
" W) k9 K) D- t# J: }6 t% TDEVELOPMENT4812
6 j* A: `( f. b! q% @Sarb, S., Cimpean, A. M. and Grigoras, D. (2010). Tie2 expression in human
( s0 n3 s) l( c9 ^2 }+ gembryonic tissues. Rom. J. Morphol. Embryol. 51, 81-84.
9 X# I- \7 ]- I# c* VSchlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W.,
- |. k) F  c2 Q1 [Deutsch, U. and Sato, T. N. (1997). Uniform vascular-endothelial-cell-specific+ X8 U3 j/ d' c
gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad.. P% i3 Z9 \' r( T! Q5 ?4 u# o
Sci. USA 94, 3058-3063.
9 L* V7 Z4 g$ ~5 J+ m! V5 K. sSchnurch, H. and Risau, W. (1993). Expression of tie-2, a member of a novel
+ t: X2 F, u7 O9 Vfamily of receptor tyrosine kinases, in the endothelial cell lineage. Development
  u8 X, O7 c' R( C! W) B9 d119, 957-968.7 r  I' j6 J, Z0 f  l: d! h4 U0 J+ ?; h
Smyth, G. (2005). limma: linear models for microarray data. In Bioinformatics and
2 B" I5 @& t$ x/ G5 O  ]+ p9 {+ dComputational Biology Solutions Using R and Bioconductor (ed. V. J. C. Robert
: |1 g# p  G3 eGentleman, W. Huber, R. A. Irizarry and S. Dudoit), pp. 397-420. New York:, T' L/ n* }  e* G- {# T/ [+ [; w
Springer.
: g6 |6 T+ M8 N6 r( B5 U+ b# ?Stanley, E. G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L. and, r8 g! k3 @' v: z0 u
Harvey, R. P. (2002). Efficient Cre-mediated deletion in cardiac progenitor cells! F( W! T1 p' H
conferred by a 3UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev.3 T, }# R9 G2 q, d3 a( R% \0 v
Biol. 46, 431-439.- c, v% s' z: f  e8 e% u# E
Takakura, N., Yoshida, H., Ogura, Y., Kataoka, H. and Nishikawa, S. (1997).
2 ~7 B3 d2 v! U7 N" x; kPDGFR alpha expression during mouse embryogenesis: immunolocalization
7 l3 E5 w% F( j  [- canalyzed by whole-mount immunohistostaining using the monoclonal anti-
4 p9 P0 Y1 H% x, _( B7 l* Nmouse PDGFR alpha antibody APA5. J. Histochem. Cytochem. 45, 883-893.4 V, B! H: `) F& D
Wei, Y. and Mikawa, T. (2000). Fate diversity of primitive streak cells during heart" q7 H8 x% c! a
field formation in ovo. Dev. Dyn. 219, 505-513.
" ]" ]. Z# u' y1 v7 E. [% jWu, S. M., Fujiwara, Y., Cibulsky, S. M., Clapham, D. E., Lien, C. L.,
( |0 F; D3 I$ n* O. u: OSchultheiss, T. M. and Orkin, S. H. (2006). Developmental origin of a
3 T( H1 n. E9 _! B1 N4 K& v6 cbipotential myocardial and smooth muscle cell precursor in the mammalian
. K5 u2 ~( r- {heart. Cell 127, 1137-1150.8 R7 x% x1 z. _2 Z$ L; D) c" k4 V4 a+ F
RESEARCH ARTICLE Development 138 (21)+ O7 l) Z- U2 C3 p
DEVELOPMENT




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5